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ABSTRACT 
Background: 
Age-related macular degeneration (AMD) is the commonest cause of severe and 
irreversible loss of vision in developed countries. Currently, there are no effective 
treatments for most patients with AMD however recent advances in understanding of 
the pathogenesis of the disease have resulted in the development of potential new 
therapies including intravitreal injection of anti-inflammatory corticosteroids. The 
pathogenesis of AMD has been shown to involve both immunological and 
inflammatory processes in the neural retina, retinal pigmented epithelium (RPE) 
abnormalities and changes in the underlying choroidal vascular circulation. 
Microglial cells are the resident immunocompetent cells of the retina, and recent 
studies indicate their involvement in the pathogenesis of AMD. Compromise of the 
blood-retinal barrier at the level of the RPE is also an important process in the 
development of subretinal choroidal neovascularisation in exudative AMD. The 
involvement o( the choroidal vasculature, including choroidal leukocytes and the 
angiogenic signals to neovascularisation in AMD remain to be fully understood. 
,. 
Immunohistochemistry have been used to investigate the role of specific cell 
populations in the pathogenesis of disease, while also allowing simultaneous study of 
morphological changes in pathological tissue. The exclusivity of Leukocyte 
Common Antigen (CD45) antibody for leukocyte lineage cells, including microglia 
and choroidal leukocytes, together with quantitative image analysis techniques 
provides a practical and theoretical basis for the measurement of the inflammatory 
cell content of ocular tissues. CD45 also has important functions in immune 
regulation and is a critical component in signal transduction in T and B lymphocytes. 
The application of quantitative immunofluorescence techniques to the study of CD45 
in AMD may contribute significantly to our understanding of the role of leukocytes 
and inflammation_ in the pathogenesis of this disease. 
This thesis aims to test the hypothesis that retinal microglia, choroidal leukocytes and 
the immunofunctional protein CD45 are involved in the pathogenesis of AMD. 
Specifically these studies will develop quantitative immunofluorescence digital 
image analysis techniques, combined with confocal microscopy, to determine if there 
Ill 
are differences between the levels of CD45 expression and cellular morphology of 
retinal microglia and choroidal leukocytes in specimens from normal young and 
normal aged eyes, and both incipient and late stage AMD-affected eyes. 
Methods: 
Donor human eyes ranging from 5 - 94 years of age (n=45) were obtained, 
subsequent to informed consent through the Lions New South Wales Eye Bank, and 
with approval of the Human Ethics Committee, University of Sydney. Following 
removal of the anterior segment and vitreous, specimens were fixed in 2% 
paraformaldehyde/ O.lM PBS (pH 7.4) and stored at 4°C. Average post-mortem 
delay from time of death to fixation for all specimens was 12.3hrs +/- 4.0. Macular 
trephines of RPE and choroid were processed routinely and embedded in Epon-
araldite resin. Semithin sections were cut and graded by light microscopy for 
presence or absence of drusen, basal laminar deposit, RPE abnormalities, disciform 
scars with choroidal neovascularisation or geographic atrophy (GA). Based on this 
histopathological survey, corresponding neural retinal samples were classified into 
three groups: young normal(< 40 years), aged normal (>75 years) and AMD. The 
AMD group was- further classified into subgroups: drusen, basal laminar deposit, 
RPE abnormalities, disciform scar and GA. 
Human retinal flatmounts and frozen sections of retina and choroid from normal and 
AMD eyes were subsequently examined for CD45 immunoreactivity by fluorescent 
immunohistochemistry, confocal microscopy and automated digital image analysis. 
Routine immunoperoxidase labelling was also used for manual counts of choroidal 
CD45-immunolabelled leukocytes. A comparison of automated quantitative 
immunofluorescence digital image analysis and manual counts of 
immunoperoxidase-labelled choroidal leukocytes was used to establish the reliability 
of the quantitative analysis. Quantitative immunohistochemistry techniques . were 
subsequently used to investigate and quantify the expression of CD45 and MHC-II 
antigen in a clinicopathological case study, where a patient with bilateral recent onset 
subfoveal choroidal neovascularisation was· treated in one eye with intravitreal 
triamcinolone acetonide (TA), whilst the fellow eye was not treated. The patient died 
6 weeks later from an unrelated cause and donated her eyes for research. This 
tV 
allowed a unique opportunity to examine histopathologically the in vivo effects of 
intravitreal corticosteroids on retinae with exudative AMD. 
Results: 
Morphological analysis of microglia revealed increased hypertrophy and features of 
microglial activation in AMD specimens compared with young normal and age-
matched controls. Quantitative assessment of CD45 expression on choroidal 
leukocytes using automated digital image analysis was consistent with manual counts 
ofimmunoperoxidase labelled choroidal leukocytes. Using the digital image analysis 
technique and immunofluorescent labelling for CD45 antigen, retinal microglia and 
choroidal leukocytes showed increased levels of CD45 immunoreactivity in AMD, 
especially for incipient AMD with abnormal RPE and late stage disciform AMD. In 
late AMD lesions (disciform scar and GA), a significant increase in the number of 
choroidal leukocytes and a corresponding increase in the level of choroidal CD45 
expression was observed when compared to incipient AMD lesions (and to young 
and age-matched normal retina). 
In the clinicopathological case study, quantitative analysis revealed both decreased 
microglia numbers and decreased expression of CD45 and MHC-II markers in the 
TA-treated eye compared to the untreated eye. Both specimens showed sub-RPE 
exudation, this being less pronounced· in theTA-treated eye. 
Conclusion: 
The present studies demonstrate that in situ measurement of inflammatory cells 
(leukocytes) in normal and AMD retinae and choroid is possible using automated 
quantitative image analysis of immunofluorescent labelled specimens. Moreover, the 
quantitative increases in CD45 expression observed on retinal microglia and 
choroidal leukocytes in AMD, especially incipient AMD with abnormal RPE and 
late stage disciform AMD, further support the hypothesis that inflammatory and 
immunological mechanisms are important in the pathogenesis of AMD. In the 
clinicopathological case study, clinical evidence of sub-RPE fluid resorption and 
down regulation of microglial activity (including CD45 expression) following T A 
treatment highlights the potential application of corticosteroids for targeting and 
inhibiting cellular mechanisms involved in the pathogenesis of AMD. Further studies 
v 
are required to investigate the immunoregulation of retinal microglia and choroidal 
leukocytes (including the role of corticosteroids), to assess the involvement and 
regulation of various growth factors important for choroidal neovascularisation and 
to develop potential therapies for AMD, including specific targeting of CD45 
glycoprotein, increasingly recognised as an important immune regulator. 
Vl 
PUBLICATIONS 
Papers 
Penfold PL, Wong JG, Gyory J and Hillson FA. (2001). "Effects of triamcinolone 
acetonide on microglial morphology and quantitative expression of MHC-II m 
exudative age-related macular degeneration." Clin Exp Ophthalmol29: 188-92. 
Wong JG, Madigan MC and Penfold PL. (2004). Leukocyte Common Antigen 
(CD45) expression in age-related macular degeneration: Quantitative analysis of 
retinal microglia and choroidal leukocytes. Submitted Br J Ophthalmol. 
Abstracts 
Wong JG, Madigan MC, Hillson FA and Penfold PL. (2001). "Quantification of 
Leukocyte Common Antigen (CD45) expression in macular degeneration." Invest 
Ophthalmol Vis Sci 42: S227: 1222. 
Wong JG, Penfold PL, Madigan MC and Billson FA. (1999). "Leukocyte Common 
Antigen (CD45) expression in macular degeneration - A measure of retinal 
inflammation." Australian Ophthalmic Visual Sciences Abstracts ( 45). 
Book Chapter 
Penfold, PL. Wong, J van Driel, D, Provis, JM and Madigan, MC. Immunology & 
Age-Related Macular Degeneration. In: "Age-Related Macular Degeneration: 
Science and Medicine in Practice.'' Springer-Verlag. In press. 
·. 
vii 
ACKNOWLEDGEMENTS 
I am indebted to many people who have helped and encouraged me during 
the course of this work. I would like to thank my supervisors: Dr Philip Penfold for 
his guidance, enthusiasm and insightful thoughts regarding the conceptual content of 
this thesis; Professor Frank Billson for encouragement, direction and the opportunity 
to perform research in the Save Sight Institute, and Dr Michele Madigan for her 
incessant support, generosity with time and helpful, practical suggestions (especially 
over nice cups of tea). 
I am grateful to Associate Professor Jan Provis who was a constant source of 
invaluable information and helpful suggestions, Mr Raj Devasahayam of the Lions 
NSW Eye Bank for useful advice on donor specimens, Dr Vera Terry from the 
Department of Anatomy, University of Sydney for advice on confocal microscopy 
and Ms Li Wen for advice on preparation of tissue culture experiments. I also 
appreciated the help of everyone in the Save Sight Institute, University of Sydney for 
creating such a supportive and enjoyable working environment, including Professor 
John MeA voy, A/Prof. Mark Gillies, Dr Kathy McClellan, Dr Simon Collier, Dr 
Richard Stump, Diana van Driel, Marina Tretiach, Jenny Wyndham, Jason Stayt, 
Kathy Wu and Svetlana Cherapanoff. 
Special thanks must go to Trent Sandercoe and Pierre Georges for their 
helpful, practical advice, relentless source of good humour and entertaining soccer 
and balcony crossword matches! I would also like to especially thank Lena Caruso 
and Dr Angela Hales for practical experimental tips as well as many witty, 
entertaining times and in particular Dr Leese Cornish for being such a great laptop-, 
labtop-, sashimi- and Chifley-pick-me-up-juice buddy. 
Financial support for this work was provided by a University of Sydney 
Postgraduate A ward, for which I am grateful. 
I would especially like to thank my family for their constant encouragement 
and support and assistance in myriad ways beyond the call of duty! Finally I would 
like to thank my beautiful wife, Polly for her enduring encouragement, support and 
patience during the course of this work. 
viii 
TABLE OF CONTENTS 
DECLARATION 
ABSTRACT 
PUBLICATIONS 
ACKNOWLEDGEMENTS 
TABLE OF CONTENTS 
LIST OF ABBREVIATIONS 
LIST OF FIGURES 
LIST OF TABLES 
CHAPTER 1: Immunological and Inflammatory Aspects 
of Age-Related Macular Degeneration-
Literature Review 
1.1 
1.2 
1.3 
1.4 
1.5 
1.6 
1.7 
Introduction 
The Macula 
The Immune Status of Normal Retina 
1.3.1 The Blood Retinal Barrier 
1.3.2 Microglia 
The Choroid 
AMD: Epidemiology 
AMD: Risk Factors 
AMD: Classification 
1. 7.1 Incipient AMD 
1.7.1.1 Drusen 
1.7.1.2 Basal deposits 
Page 
11 
lll 
Vll 
viii 
lX 
XIV 
XV 
XVlll 
2 
2 
3 
4 
4 
6 
7 
7 
8 
8 
8 
10 
1. 7.1.3 Retinal Pigmented Epithelium (RPE) abnormalities 12 
ix 
1.7.2 LateAMD 12 
1. 7.2.1 Exudative AMD 12 
1. 7.2.2 Atrophic AMD 14 
1.8 AMD: Pathogenesis 14 
1.8.1 Immunity and AMD 14 
1.8.1.1 Humoral immunity 15 
1.8.1.2 Other humoral factors 15 
1.8.2 Inflammation and AMD 16 
1.8.2.1 Chronic inflammation 16 
1.8.2.2 Macrophages 17 
1.8.2.3 Role of microglia in inflammation 18 
1.8.2.4 Growth factors and cytokines 19 
1.9 AMD: Treatment 20 
1.9.1 Treatment for Non-exudative AMD 20 
1.9.2 Treatment for Exudative AMD 21 
1.9.2.1 Laser and surgical treatment 21 
1.9.2.2 Intravitreal corticosteroid treatment 22 
1.10 Hypothesis and Aims 25 
CHAPTER2: A Rationale for Quantitative Immunofluorescence, 
Confocal Microscopy and Digital Image Analysis 
2.1 
2.2 
2.3 
2.4 
Introduction 
Fluorescence Immunohistochemistry 
. Confocal Microscopy 
Quantitative Image Analysis 
2.4.1 Counting of Immunoreactive Structures 
2.4.2 Measurement oflmmunoreactivity Intensity 
2.4.3 Previous Methods of Quantitative Immunohistochemistry 
using Transmission Light Microscopy 
2.4.4 Image Processing and Analysis 
28 
29 
30 
31 
31 
32 
33 
34 
X 
2.4.5 Rationale for the Development of a Quantitative Confocal 35 
Immunofluorescent Technique 
CHAPTER3: Leukocyte Common Antigen (CD45) Expression in 
Age-Related Macular Degeneration: Quantitative 
Analysis of Retinal Microglia and Choroidal 
Leukocytes. 
3.1 Introduction 
3 .1.1 CD45: Functions 
40 
40 
3.1.2 CD45 Expression in Normal Retina 41 
3.1.3 Microglial Activation and CD45 Expression in Other Neural 42 
Pathology 
3.1.4 The Role of Choroidal Leukocytes in the Pathogenesis of AMD 44 
3.1.5 CD45 Expression and AMD 45 
3.2 Methods . · 46 
3.3 
3.2.1 Specimens 
3.2.2 Tissue Preparation 
3.2.3 Classification 
3 .2.4 Immunohistochemistry 
3.2.4.1 Indirect immunofluorescence labelling 
3. 2 .4.1.1 Retinal flatmounts 
3.2.4.1.2 Frozen sections 
3.2.4.2 Indirect immunoperoxidase labelling 
3.2.5 Confocal Microscopy 
3.2.6 Digital Image Analysis 
3.2.7 Statistical Analysis 
Results 
3.3.1 Morphological Results 
3.3.1.1 Normal retinae 
3.3.1.2 AMD retinae 
3.3.2 Quantitative Image Analysis 
46 
47 
47 
48 
48 
48 
48 
49 
49 
50 
51 
51 
51 
51 
51 
52 
xi 
3.4 
3.3.2.1 CD45-Iabelled retinal microglia inflatmounts 52 
3.3.2.2 CD45-Iabelled choroidal leukocytes 53 
3.3.3, Manual Counts ofCD45-labelled choroidal leukocytes 53 
Discussion 54 
3 .4.1 The role of microglia in the pathogenesis of AMD 55 
3.4.1.1 Morphological changes 55 
3.4. 1.2 CD45 expression in retinal microglia 56 
3.4.2 The role of choroidal leukocytes in the pathogenesis of AMD 57 
3.4.3 Differential expression of CD45 on retinal microglia and 58 
choroidal leukocytes in AMD subgroups 
3.4.4 Validity of quantitative fluorescent immunohistochemical 59 
technique 
3.4.5 Summary 59 
CHAPTER4: Effects of Triamcinolone Acetonide on Microglial 
Morphology and Expression ofCD45 and MHC-II 
in Exudative Age-Related Macular Degeneration 
4.1 Introduction 62 
4.2 Methods 64 
4.2.1 Clinical Details 64 
4.2.2 Tissue Preparation 65 
4.2.3 Immunohistochemistry 65 
4.2.3.1 Quantitative immunofluorescence 65 
4.2.3.2 Frozen sections 65 
4.2.3.3 Indirect immunoperoxidase labelling 66 
4.2.4 Confocal Microscopy 67 
4.2.5 Digital Image Analysis 67 
4.2.6 Statistical Analysis 67 
4.3 Results 68 
4.3.1 Light Microscopy Histopathology 68 
4.3 .2 Immunohistochemistry 68 
4.3.2.1 CD45 immunoreactivity 68 
xii 
4.3.2.2 MHC-II immunoreactivity 
4.4 Discussion 
4.4.1 MHC-II Immunoreactivity 
4.4.2 CD45 Immunoreactivity 
4.4.3 Clinical Relevance 
CHAPTER 5: Conclusions 
69 
70 
71 
72 
73 
APPENDICES ·77 
REFERENCES 83 
xiii 
·. 
AMD 
BlamD 
BLD 
BlinD 
BRB 
CD 
CD45 
CNS 
DS 
GA 
GCL 
GFAP 
HLA 
ICAM-1 
IL 
INL 
IPL 
LCA 
MHC 
MPS 
NFL 
NOS 
OPL 
PAS 
PBS 
PD 
PDT 
RPE 
SP 
TA 
TBS 
TNF 
zo 
LIST OF ABBREVIATIONS 
Age-Related Macular Degeneration 
Basal Laminar Deposit 
Basal Laminar Deposit 
Basal Linear Deposit 
Blood-retinal Barrier 
Clusters of Differentiation 
Leukocyte Common Antigen 
Central Nervous System 
Disciform Scar 
Geographic Atrophy 
Ganglion Cell Layer 
Glial Fibrillary Acidic Protein 
Human Leukocyte Antigen 
Intracellular Adhesion Molecule-! 
Interleukin 
Inner N:uclear Layer 
~er Plexiform Layer 
Leukocyte Common Antigen 
Major Histocompatibility Complex 
Mononuclear Phagocyte Series 
Nerve Fibre Layer 
Nitric Oxide Synthase 
Outer Plexiform Layer 
Periodic Acid Schiff 
Phosphate-buffered Saline 
Pigmentary Disturbance (RPE abnormalities) 
Photodynamic Therapy 
Retinal Pigmented Epithelium 
Substance P 
Triamcinolone Acetonide 
Iris-buffered Saline 
Tumour Necrosis Factor 
Zonula Occludens 
xiv 
LIST OF FIGURES 
Figure l.la Inverted fluorescent image ofCD45-labelled microglia in retinal 
flatmount specimen. 
Figure l.lb Isolated CD45·labelled microglia in mixed human glial cell culture. 
Figure 1.2a Clinical fundus photograph of hard drusen. 
Figure 1.2b Post-mortem photograph of calcified hard drusen surrounding an area 
of geographic atrophy at the macula. 
Figure 1.3 Light and electron microscopy semithin sections showing drusen with 
overlying hypertrophic retinal pigment epithelium and choroidal 
leukocytes. 
Figure 1.4a Clinical fundus photograph of retinal pigment abnormalities 
consisting of hyper- and hypopigmentary changes at the macula. 
Figure 1.4b Postmortem eyecup photograph of retinal pigment abnormalities at 
the macula of a donor AMD specimen. 
Figure 1.5 Semithin section showing retinal pigment epithelial abnormalities 
and 91-sorganization overlying Bruch's Membrane. 
Figure 1.6 Clinical fundus photograph of choroidal neovascular membrane in 
exudative AMD with extensive subretinal haemorrhage and 
exudation. 
Figure 1. 7 Extensive disciform scar involving the macula in a patient with late 
stage exudative AMD. 
Figure 1.8 Semithin sections showin·g established disciform scar and choroidal 
neovascularisation. 
Figure 1.9a Clinical fundus photograph showing macular geographic atrophy. 
Figure 1.9b Post-mortem eyecup photograph showing geographic atrophy at the 
macula of a donor AMD specimen. 
Figure 1.10 Semi thin section at the edge of geographic atrophy lesion showing 
' 
Figure 2.1 
Figure 2.2 
gliosis and RPE abnormalities. 
Three-step indirect fluorescent technique of inununohistochemistry 
Principle of confocal microscopy 
XV 
Figure 2.3a Immunohistochemistry techniques: Normal binding of antibody-
antigen complexes. 
Figure 2.3b Immunohistochemistry techniques: The Bigbee Effect 
Figure 2.4 Immunohistochemistry techniques: Sterle hindrance 
Figure 3.1 Methodology for Immunofluorescent Quantitative Image Analysis 
based on Confocal Microscopy and Digital Image Analysis 
Figure 3.2 Immunoperoxidase-labelled CD45-positive microglia in the normal 
retina demonstrating laminar topography. 
Figure 3.3 Inverted fluorescent image of CD45-labelled parenchymal type 
microglia in normal retina. 
Figure 3.4 Inverted fluorescent image ofCD45-labelled ramified type microglia 
in normal retina. 
Figure 3.5 Inverted fluorescent image of CD45-labelled microglia of dendritic 
type in normal retina. 
Figure 3.6 CD45-labelled parenchymal microglia in an AMD specimen. 
Figure 3. 7 Immunofluorescent CD45-labelled retinal microglia in a section of an 
AMD specimen, showing laminar distribution. 
, 
Figure 3.8a Inverted fluorescent image ofCD45-labelled microglia in an AMD 
(geographic atrophy) specimen. 
Figure 3.8b Magnified confocal fluorescent image ofCD45-labelled parenchymal 
microglia in normal retinae and AMD retinae. 
Figure 3.9a-e Inverted fluorescent images ofCD45-labelled microglia in AMD 
subgroups in retinal flatmount specimens. 
Figure 3.10a Aged normal frozen sections double-labelled with CD45 and GF AP 
(Glial Fibrillary Acidic Protein). 
Figure 3.10b AMD specimen frozen sections double-labelled with CD45 and 
GFAP. 
Figure 3.10c Cultured mixed human retinal glial cell labelled with CD45 and 
GFAP. 
Figure 3.11a Immunoperoxidase-labelled CD45-positive choroidal leukocytes 
below RPE in an aged normal retina. 
Figure 3.11b Immunoperoxidase-labelled CD45-positive retinal microglia and 
groups of choroidal leukocytes below the RPE in an AMD retina. 
xvi 
Figure 4.1 
Figure 4.2 
Figure 4.3 
Figure 4.4 
Figure 4.5 
Figure 4.6 
Figure 4.7 
Figure 4.8 
Pre-treatment fundus photos showing patient with bilateral 
subretinal neovascular membranes. 
Left fundus photos before intravitreal triamcinolone injection and 2 
weeks after treatment. 
Early and late phase fluorescein angiograms before intravitreal 
triamcinolone treatment, 2 weeks and 6 weeks following treatment. 
Semithin resin sections of outer retina of untreated and triamcinolone-
treated specimens. 
Immunoperoxidase-labelled CD45-positive microglia in untreated and 
triamcinolone-treated AMD retinae. 
Untreated and triamcinolone-treated AMD retinae double-labelled 
with CD45 and GF AP. 
Immunoperoxidase-labelled CD45-positive microglia and choroidal 
leukocytes in triamcinolone- treated retina. 
Immunoperoxidase-labelled MHC-II-positive microglia and vascular 
endothelial cells in untreated and triamcinolone-treated AMD retinae. 
Figure Appendix ll.l CD45-labelled U937 cells at low and high magnification, 
examined by scanning laser confocal microscopy. 
Figure Appendix 11.2 Dilution experiments demonstrating an incremental 
relationship between total fluorescence intensity and increasing 
concentrations of CD45 antibody. 
Figure Appendix TI.3 Graph demonstrating a linear relationship between individual 
particle fluorescence and total cumulative fluorescence. 
xvii 
LIST OF TABLES 
Table 3.1a Specimen grouping by histopathological survey, showing specimen 
numbers and mean ages. 
Table 3.lb Young normal, aged normal and AMD specimens grouped by 
histopathological survey, showing delay to fixation of specimens. 
Table 3.2a Subdivision of AMD specimens by histopathological subgroup 
showing specimen numbers and mean ages. 
Table 3.2b Subdivision of AMD specimens by histopathological subgroup 
showing mean time delay to fixation. 
Table 3.3 Quantitative analysis of total fluorescence intensity ofCD45-positive 
retinal microglia in retinal flatmounts by histopathological subgroups. 
Table 3.4 
Table 3.5 
Table 3.6 
Table 3.7 
Table 4.1 
Table 4.2 
Table4.3 
Quantitative comparison of CD45 expression in retinal microglia in 
incipient AMD subgroups vs late AMD subgroups. 
Quantitative analysis of CD45 expression on choroidal leukocytes in 
AMJ?. .subgroups vs age-matched and young normal specime.ns. 
Quantitative analysis of immunofluorescent CD45-labelled choroidal 
leukocytes in incipient AMD vs late AMD lesions. 
Manual counts of immunoperoxidase-labelled CD45-positive 
choroidal leukocytes in AMD subgroups, and young and aged 
normals. 
Quantitative analysis of total retinal flatmount area labelled with 
CD45 in triamcinolone acetonide (T A) treated, untreated and control 
specimens. 
Quantitative analysis of total fluorescence intensity ofCD45-positive 
microglia in retinal flatmounts in T A treated, untreated and control 
spectmens 
Manual counts of CD45-positive microglia in retinal flatmounts in 
TA treated, untreated and control specimens 
xviii 
Table 4.4 
Table 4.5 
Table 4.6 
Table4.7 
Table4.8 
Manual counts of CD45·positive retinal microglia in frozen sections 
in TA treated, untreated and control specimens 
Manual counts of CD45-positive choroidal leukocytes in frozen 
sections in T A treated, untreated and control specimens 
Quantitative analysis of total retinal flatmount area labelled with 
MHC-ll in TA treated, untreated and control specimens 
Quantitative analysis of total fluorescence intensity ofMHC-ll 
positive cells in retinal flatmounts in T A treated, untreated and control 
specimens 
Manual counts ofMHC·II positive microglia in retinal flatniounts in 
TA treated, untreated and control specimens 
xix 
Chapter 1: Immunological and Inflammatory Aspects of AMD -Literature Review 
CHAPTER! 
Immunological and Inflammatory Aspects of Age-
Related Macular Degeneration - Literature Review 
Chapter 1: Immunological and Inflammatory Aspects of AMD -Literature Review 
1.1 INTRODUCTION 
Age-related macular degeneration (AMD) is the commonest cause of severe and 
irreversible loss of vision in developed countries and involves deterioration of the 
macula, the central portion of the retina (Fine et al. 2000). Currently, there is limited 
effective treatment for most patients however recent advances in the understanding 
of AMD have resulted in the development of potential new therapies and 
prophylactic measures. Although the exact aetiology of AMD remains unknown, the 
pathogenesis has been shown to involve immunological and inflammatory processes, 
including disturbance of the normal immune status of the retina, disrup~ion of the 
blood-retinal barrier (BRB), and activation of cellular and humoral immunity in the 
retina and choroid. The development of potential treatments with anti-inflammatory 
properties for the exudative form of AMD further supports a role for inflammation in 
some forms of the disease. However, whether the involvement of the immune system 
is a primary initiating event or consequent to other insults remains to be determined. 
This study aims to analyse the in situ expression of immunofunctional proteins on 
immune, vascular and glial cell populations in the retina by quantitative techniques, 
in order to bett~t: -define the role of the immune response in the pathogenesis of 
AMD. 
1.2 THE MACULA 
The macula is a circular region 5-6mm in diameter at the centre of the posterior pole 
of the retina with the fovea at its centre. It has the highest concentration of 
photoreceptors of any part of, the retina, which facilitates central vision and permits 
high-resolution visual acuity (Curcio et al. 1990). It has been postulated that the lack 
of a retinal blood supply in the foveal region is an anatomical specialization that 
allows the macula to be vulnerable to degenerative disease (reviewed Penfold et al. 
2001). Studies of the architecture and physiological changes in the developing· retina 
suggest that during development, displacement of ganglion cells from within the 
avascular zone towards the perifoveal capill?fY plexus places neurons and glia in an 
optimal relationship with a meagre blood supply (Provis et al. 1998). This is 
supported by animal studies involving simian primates that demonstrate the foveal 
depression has evolved to thin the retina locally, where blood supply is limited 
2 
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(Rodieck 1988). Depending on light conditions, primate photoreceptors consume 90-
100% of oxygen delivered by the choriocapillaris (Ahmed et al. 1993), leaving little 
oxygen to diffuse from the choriocapillaris into inner retina at the fovea. The 
combination of very high cell densities, high metabolic activity and a relatively 
meagre blood supply suggest that even under normal conditions oxygenation of the 
neural retina at the fovea may be barely sufficient. In the adult macula there is a 
critical balance between limited blood supply and high metabolic demand such that 
even minor perturbations of circulation, as may occur in vascular disease may lead to 
metabolic stress in foveal neurons and/ or glial cells. Such perturbations and the 
resultant 'cellular stress' may be the origin of signals that induce the changes 
associated with AMD (Penfold et al. 2001). 
1.3 THE IMMUNE STATUS OF NORMAL RETINA 
The lack of lymphatic drainage, presence of physical barriers and minimal 
expression of major histocompatibility complex (MHC) antigens have previously 
contributed to the view that neural tissue, including the retina, is immunologically 
privileged (We~~.Jle et al. 1986; Lampson 1987). Neural tissue appears to be more 
sensitive to inflammation than most other tissue and · has minimal regenerative 
capacity. Cellular immune reactions will not only lead to local damage but also to 
damage of "innocent bystander" surrounding tissues (Wekerle et al. 1986). 
Consequently, immune privilege is thought to be a physiological adaptation of the 
immune response in neural tissue to minimize inflammation in response to foreign 
antigens. However, subsequent studies have suggested that immune privilege in 
neural tissue is not absolute and both immune and autoimmune responses can occur 
(Lassmann et al. 1991). The eye, formed as a result of outpouching from the 
prosencephalon, is analogous to the brain. It has a BRB that functions to preserve the 
physiological environment of the neural retina and limit inflammatory responses, 
however it influences, but does not exclude, cell-mediated and humoral immunity. 
The finding that the retina possesses resident immune cells (microglia) with a diverse 
range of functions and the ability to influence disease processes has also 
demonstrated the importance of immunological mechanisms in retinal pathology 
(Lassmann et al. 1991 ; Penfold et al. 1993; Diaz-Araya et al. 1995; Matsubara et al. 
1999). 
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Figure l.la Inverted fluorescent image ofCD45-labelled microglia in 
retinal flatmount specimen. 
Figure l.lb Isolated Cd45-labelled microglia in mixed human glial cell 
culture (culture courtesy ofMs L. Wen). 
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1.3.1 The Blood-Retinal Barrier 
The BRB exists at two principal sites; an iilller retinal barrier consisting of retinal 
vascular endothelial cells, joined by tight junctions (zonulae occludens, ZO) and an 
outer barrier consisting of the retinal pigmented epithelium (RPE) in which adjacent 
cells are similarly joined by ZO (Claudio et al. 1994). Functionally, the BRB is 
dependent on the integrity of the RPE, the retinal vasculature and associated glia 
limitans, a sheath of cellular processes which inhibit the direct access of blood 
vessels to the neuronal environment. Present evidence indicates that th~ glia limitans 
is a compound structure in the human retina comprising contributions from at least 
four cell types: astrocytes, microglia and the terminals of nitric oxide synthetase 
(NOS) and substance P (SP) - immunoreactive amacrine cells (Provis et al. 1995; 
Greenwood et al. 2000). It has been previously reported that microglia have 
phenotypic characteristics in common with dendritic antigen-presenting cells 
(Penfold et al. 1993) and are constituent cells of the glia limitans of the human retina 
(Penfold et al. 1991; Provis et al. 1995). The RPE (outer BRB) utilizes the same 
principle receptor-ligand pairings (intracellular adhesion molecule-1 (ICAM-1) and 
_,.-
lymphocyte function-associated antigen-1 (LFA-1)) in controlling lymphocyte traffic 
into the retina as vascular endothelium. Increased levels of soluble ICAM -1 in serum 
have been found to be associated with retinal vasculitis and dysfunction of the BRB 
(Palmer et al. 1996). The RPE is a common site for inflammatory attack resulting in 
breakdown of barrier functions and choroidal neovascularization (Vinores et al. 
1994; Devine et al. 1996). 
1.3.2 Microglia 
Neural tissue contains two main classes of cells: neurons and glia. Whilst neurons are 
specialized for the generation and transmission of nerve impulses, glia have 
important ancillary functions. The human retina has both macroglia (astrocytes and 
Muller cells) and microglia (Figures l.la,b). It is now well established that microglia 
in neural tissue are capable of a wide range of immunological processes, including 
antigen presentation and complement activation (Streit et al. 1988; Graeber 1993; 
GehrmaiUl et al. 1995; Carson et al. 1998). Microglia were first described by del Rio-
Hortega (1932) who proposed that they represented the reticulo-endothelial system in 
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the central nervous system (CNS) and that they had the potential to intervene in 
inflammatory processes in neural tissue. 
In normal CNS, multiple forms of microglia have been described and are generally 
referred to as "amoeboid", "ramified" and "reactive" forms (Thomas 1992). The 
amoeboid form is found in developing brain tissue and is thought by some to be the 
precursors of the ramified form (Hutchins et al. 1990). Amoeboid microglia appear 
similar to macrophages, both having a broad flat morphology with pseudopodia 
(Ling and Wong 1993). The ramified or "resting" form is found in normal adult brain 
tissue and has a small cell body from which many thin branching processes arise. 
Reactive microglia are thought to be transformed from ramified forms in response to 
pathology and are characterized by an oval to rod-shaped morphology devoid of 
ramified processes (Streit et al. 1988; Streit and Kreutzberg 1988; Thomas 1992). 
In adult human retinae, subpopulations of microglia are found: perivascular 
microglia are immunoreactive for macrophage antigens, MHC-1 and MHC-II and are 
localized within the perivasular space (Graeber 1993; Provis et al. 1995). A similar 
.. 
group are vessel-associated, but located outside the perivascular space and have been 
referred to as paravascular microglia (Provis et al. 1995). Paravascular microglia 
expressed increased levels of MHC-1 and -II antigens compared to parenchymal 
microglia and were also macrophage (S22) antigen-positive (Provis et al. 1995). A 
distinct subset of the CNS parenchymal (ramified) microglia do not contribute 
structurally to the glia limitans but differentially express MHC antigens (Provis et al. 
1995). 
Expression of MHC antigens is conventionally associated with antigen presentation 
and promotion of immune responses, where MHC-II antigens are responsible for the 
presentation of exogenously derived peptides and MHC-I antigens for the 
presentation of endogenously derived peptides. Constitutive expression of MHC-1 
and -II antigens by human retinal microglia, along with other phenotypic 
characteristics reflects their role as resident dendritic antigen-presenting cells of the 
retina (Streilein et al. 1992; Penfold et al. 1993; Yang et al. 2000). Similar 
observations have been made in.porcine retina (Yang et al., 2002). OX-6 (MHC-11)-
positive cells have also been observed in normal rat retinae (Zhang et al. 1997), and 
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freshly isolated rat microglia express phenotypic and functional characteristics 
supporting their role as antigen-processing and -presenting cells in the retina 
(Broderick et al. 2000). Human retinal microglia in vitro also express the accessory 
molecule CD86 (B7-2) (Diaz et al. 1998) and in situ, are immunoreactive for a 
number of human leukocyte markers, including CD45, CD68, and S22 macrophage 
antigen (Penfold et at. 1991; Yang et al. 2000). Similarly cultured rat retinal 
microglia constitutively express B7-2, macrophage antigens and ICAM-1 (Matsubara 
et al. 1999). Human retinal microglia can be thus be considered as a heterogeneous 
population of leukocytes comprising both macrophages and dendritic cells (Penfold 
et al. 1991; Yang et al. 2000). Some studies have found that in most tissues dendritic 
cells and macrophages co-exist, macrophages apparently acting to suppress the 
antigen presenting functions of the resident dendritic cells (Holt et al. 1985; Pavli et 
al. 1993; Liew et al. 1994; Broderick et al., 2002). 
1.4 THE CHOROID 
The choroid consists of a thick segmental network of blood vessels of decreasing 
diameter embedd¢ in a ground substance of loose connective tissue with collagen, 
elastic and reticular fibres immediately below Bruch's membrane and the RPE 
(Richard 1992), supplying nutrients 'to the outer retina. The choriocapillaris forms a 
J 
three-dimensional mosaic of lobes adjacent to Bruch's membrane, containing 
fenestrated endothelial cells which allow the passage of small molecules and fluid. 
The choroid contains a significant leukocyte cellular component, including 
macrophages, lymphocytes, plasma cells and mast cells (Richard 1992). Leukocyte 
trafficking and extravasation through the choriocapillaris are mediated by adhesion 
molecules including P-selectin and ICAM-1 (McLeod et al. 1995). Leukocytes have 
long been established to influence angiogenesis and inflammatory processes 
(Auerbach 1981 ), including within the choroid. A structurally and functionally 
normal choroidal vasculature is essential for normal function of the retina, with 
compromised choroidal blood flow resulting in photoreceptor dysfunction and death 
(Cao et al. 1998). Anatomical and physiological specialization of the submacular 
choroid, including higher blood flow, shorter, more perpendicular supplying 
arterioles and watershed regions may also contribute to the vulnerability of the 
6 
~ 
Chapter 1: Immunological and Inflammatory Aspects of AMD-Literature Review 
macular region to ischemic insult (Hayreh 1975; Richard 1992; Grunwald et al. 
1998a,b). 
1.5 AMD: EPIDEMIOLOGY 
fu Australia, 1.9% of the population over 50 years have advanced age-related 
macular degeneration (AMD) (Mitchell et al. 1995), which is currently 
approximately 100,000 people (Mitchell et al. 1999). The prevalence of AMD also 
increases progressively with increasing age, with rates ranging from 0% (under 55 
years) to 0.7% (65-74 years), and 5.4% (75-84 years) to 18.5% (over 85 years old) 
respectively. Features associated with incipient AMD have been found in 13.3% of 
people (Mitchell et al. 1995). The direct cost for a single blind person with AMD has 
been estimated to be approximately$ 15000 per annum in Australia (Wright et al. 
2000), and the economic burden of management of AMD upon future health 
resources continues to increase as the population continues to age. 
1.6 AMD: RISK FACTORS 
Population ~tudies indicate that the most significant risk factor for AMD is age, 
followed by smoking, which is associated with an overal1 four-fold increased 
incidence or odds ratio (OR)= 3.9 (Smith et al. 1996). The association of smoking 
with AMD was found to be strongest for the duration of smoking, especially over 40 
years (OR)= 3.26, and it is estimated that 14% of AMD cases may be attributable to 
cigarette smoking (Mitchell et al. 1999). Consistent with the hypothesis that 
oxidative stress from smoking may play a role in the aetiology of AMD, nutritional 
factors and levels of antioxidant intake have also been found to be associated with 
risk of progression of the disease. The Age-Related Eye Disease Study (AREDS) 
suggests a moderate beneficial effect of antioxidant, vitamin and zinc dietary 
supplementation in reducing progression to severe AMD (Age-Related Eye· Disease 
Study Research 2001; Hyman and Neborsky 2002). Many other studies have 
investigated specific modifiable and non-modifiable risk factors for AMD and 
incipient AMD, including genetic influences, refractive error, iris colour, 
cardiovascular disease, systemic disease, chemical and sunlight exposure. However, 
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Figure 1.2a Clinical fundus photograph of hard drusen at the posterior 
pole of a patient with incipient AMD (courtesy of Prof F. Billson and Dr G. 
Painter) 
Figure 1.2b Post-mortem photograph of calcified hard drusen 
surrounding an area of geographic atrophy at the macula in a donor AMD 
spectmen. 
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these risk factors have been shown to be less strong on multivariate analysis 
(McCarty et al. 2001). 
1.7 AMD: CLASSIFICATION 
Classification of AMD may be divided into early or incipient AMD (also termed age~ 
related maculopathy or ARM) which includes drusen, basal deposits and RPE 
abnormalities and late stage AMD which has two main types: the "wet" or exudative 
form and the "dry,, non-exudative or atrophic form. 
1.7.1 Incipient AMD 
1.7.1.1 Drusen 
Drusen appear clinically as focal, whitish-yellow excrescences under the retina, 
usually clustering at the posterior pole (Figures 1.2a,b ). Drusen are widely variable in 
number, size, pigmentation, distribution and elevation and may be categorized into 
two main types: hard and soft. Hard drusen appear clinically as small, yellow, 
punctate deposits! soft drusen are often paler, larger deposits with poorly demarcated 
boundaries. The presence of large, bilateral or numerous drusen are significant risk 
factors for developing late stage AMD. Hard drusen are more closely associated with 
geographic atrophy (GA) whilst patients with soft drusen and pigment clumping have 
an increased risk of choroidal neovascularisation (Fine et al. 2000). Further evidence 
supporting the association of drusen with late stage AMD and photoreceptor death 
has been reported recently (Johnson et al. 2003). Retinal cells directly overlying both 
soft and hard drusen were shown to exhibit structural and molecular abnormalities 
indicative of photoreceptor degeneration and Muller glial activation, suggesting that 
photoreceptor cell function is compromised as a consequence of drusen formation 
(Johnson et al. 2003). Histopathological studies have shown drusen to be correlated 
to PAS-positive deposits between the RPE and Bruch's membrane (Figures 1.3a,b). 
More recently, drusen were found to contain immunological and inflammatory 
components, suggesting that the pathogenesis of drusen involves immunocompetent 
cells and that drusen may be a by-product of immune responsiveness (Hageman et al. 
2001). 
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Figure 1.3a Light microscopy semithin sections showing drusen (D) 
above Bruch's Membrane (BM), with overlying hypertrophic abnormal 
retinal pigment epithelium (RPE) and choroidal leukocytes (L) (courtesy of 
Dr P. Penfold and Dr J. Provis). 
Figure 1.3b Electron microscopy sections showing drusen (D) above 
Bruch' s Membrane (BM), and hypertrophic retinal pigment epithelium (RPE) 
granules (Bar = lOJ.tm) (courtesy of Dr P. Penfold and Dr J. Provis). 
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The aetiology of drusen remains to be fully established, however, two basic 
hypotheses exist concerning the origin of drusen constituents: either they are derived 
from the RPE or from the choroidal vasculature. Many studies support a choroidal 
vasculature origin, based on clinical and histological observations including 
demonstration of a relationship between choriocapillaris vascular units and a 
segmental distribution of drusen in Bruch's membrane (Friedman et al. 1963; Tso 
1985). Both Gass (1967) and Sarks (1982) have pointed out that drusen fluoresce 
early, and continue to fluoresce late, when examined by fluorescein angiography. 
Gass (1967) also noted that the staining of drusen by fluorescein appeared to be a 
result of fluorescein leaking into the drusen from the underlying choriocapillaris. The 
histological and clinical similarities between drusen and serous detachments 
suggested that they may have a common aetiology, and that most sub-RPE deposits 
may be derived from the choriocapillaris (Gass 1967). The hypothesis that drusen 
constituents are derived from the RPE has arisen from histological and ultrastructural 
observations (Abdelsalam et al. 1999). Farkas et al. (1971) suggested that defects in 
Bruch's membrane allowed accumulation of drusen material from RPE cells. The 
presence of cytoplasmic profiles and fibrous material in drusen led Bums and 
Feeney-Bums (1980) to the postulate that the RPE cells shed cytoplasm into drusen 
thus contributing to their formation. Althougll the evidence for a choroidal origin of 
the constituents of drusen appears more substantial than that supporting an origin 
from the RPE, a contribution from both sources remains a possibility. 
Recent studies of the pathogenesis of drusen suggest that drusen biogenesis may be a 
by-product of immune responsiveness. A number of plasma proteins have been 
identified as molecular components of drusen, many of which are acute phase 
reactant proteins with established roles in mediating immune responsiveness 
(Johnson et al. 2000). Concentrations of immunoglobulin G and terminal C5b-9 
complement complexes were found to be present in drusen in addition to cytoplasmic 
immunoreactivity for immunoglobulin and the C5 component of complement in 
retinal pigment epithelial cells overlying or directly adjacent to drusen (Johnson et al. 
2000). These results implicate an immune complex-mediated pathogenesis involving 
RPE cells, as an initiating event in drusen formation (Johnson et al. 2000). 
Immunoreactive components such as immunoglobulin light chains, complement 
proteins (C5 and C5b-9 complex) as well as vitronectin, serum amyloid P 
9 
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component, apolipoprotein E, and Factor X, have also been reported in drusen 
(. phenotypes (Mullins et al. 2000). Transcripts encoding some of these molecules were 
' 
also found to be synthesized by the retina, RPE and choroid, further supporting the 
involvement of inflammatory and immunological processes in both choroid and 
retina, in drusen formation and development of incipient AMD (Mullins et al. 2000). 
Other studies have investigated the similarities in the components of drusen in AMD 
and extracellular deposits in other diseases such as Alzheimers disease and 
atherosclerosis. Anderson et al. (2002) suggested that drusen production is analogous 
to the process that occurs in other age-related diseases, such as Alzheimer's disease 
and atherosclerosis, where accumulation of extracellular plaques and deposits elicits 
a local chronic inflammatory response that ·exacerbates the effects of primary 
pathogenic stimuli. Hageman et al. (200 1) recently proposed an integrated hypothesis 
that considered drusen as biomarkers of immune-mediated processes at the RPE-
Bruch's membrane in ageing and AMD. Cell and immune-mediated processes were 
found to have a potential direct role in drusen biogenesis, including the close 
association of HLA-DR and CD antigens with drusen solitary core-like domains. 
Dendritic cells have also been implicated in drusen pathogenesis. The drusen 
glycoprotein core domains have been linked ultrastructurally to choroidal leukocyte 
cell bodies on the other side of Bruch's membrane, which are immunoreactive for 
CDla, CD83, CD86 and MHC-II ofthe monocytic leukocyte lineage (Mullins et al. 
2000). Hageman et al (2001) also noted that in evaluating the mechanisms of drusen 
formation, it is difficult to explain the presence of some drusen-associated molecules 
such as CSb-9, immunoglobulin and MHC-II antigens without invoking immune-
mediated events (Hageman et al. 2001). Overall, these studies suggest that a number 
of drusen-associated constituents are active participants in humoral and cellular 
immune and/or inflammatory processes. Taken together, it is reasonable to propose 
that immune-related processes may be important in drusen development anp thus 
related to increased risk for the development of both exudative and atrophic AMD. 
1.7.1.2 Basal Deposits 
Basal linear deposit (BLD) is a histopathological term to describe a finely granular 
deposit situated between Bruch's membrane and the RPE (Sarks 1976). BLD is not 
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visible ophthalmoscopically, unlike drusen, although both deposits can be identified 
at the light microscope level. BLD and drusen may occur simultaneously in some 
specimens, the BLD being located between the drusen and the RPE but remaining 
separated from the drusen by the basement membrane of the RPE. The distinct 
relationship of drusen and BLD to the RPE and Bruch's membrane suggests that they 
have separate aetiologies. 
Histological studies have revealed increased deposition of BLD associated with the 
progressive development of AMD, and it was suggested that BLD was a product of 
the degenerating RPE. However, Gass (1967) noted the presence of a similar deposit 
lying between Bruch's membrane and the RPE associated with disciform AMD, and 
suggested that most sub-pigment epithelial deposits are derived from the choroid. 
Subsequently, van der Schaft et al. (1991) identified BLD in both young and old eyes 
(and many other organs and tissues), suggesting that the precursors of BLD may be 
derived from either the RPE and/or choroid and may not be specifically related to the 
pathogenesis of AMD. 
BLD is comprised of several components including wide-banded collagen, fine 
fibrillar elements and electron dense clumps, within a homogeneous basement 
membrane-like ground substance and fibronectin (Loeffler and Lee 1986). More 
recently it has been proposed that the term basal laminar deposit (BlamD) be 
confmed to deposits which primarily consist of long spacing collagen and the 
original term basal linear deposit {BlinD) be applied to deposits primarily consisting 
of membranous material (Green and Enger 1993; Loeffler and Lee 1998; Curcio and 
Millican 1999). 
Basal deposits but not nodular drusen are positively associated with choroidal 
neovascularisation disciform scarring and visual loss (Green and Enger 1993 ;. Curcio 
and Millican 1999). The presence of membranous debris (BlinD) and to a lesser 
degree BlamD, has also been recently demonstrated to be associated with early AMD 
lesions and may be a significant indicator of progression to late AMD (Green and 
Enger 1993; Curcio and Millican 1999). However, the presence of BlinD does not 
prove causality and basal deposits may occur in eyes without AMD (Green and 
Enger 1993; Curcio and Millican 1999). 
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Figure 1.4a Clinical fundus photograph of retinal pigment abnormalities 
consisting of hyper- and hypopigmentary changes at the macula region. 
(courtesy of Prof F. Billson and Dr G. Painter) 
Figure 1.4b Postmortem eyecup photograph of retinal pigment 
abnormalities at the macula of a donor AMD specimen. 
... - · p ~ ... .. ~~ ... 
Figure 1.5 Semithin section showing retinal pigment epithelial abnormalities 
(PD), with RPE hypertrophy and disorganization overlying Bruch' s Membrane (BM) 
and choriocapillaris (CC) (courtesy of Dr P. Penfold). 
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1.7.1.3 Retinal Pigmented Epithelium (RPE) Abnormalities 
RPE abnormalities (pigmentary disturbance) including hyper·pigmentation and 
hypo-pigmentation have been found to be significant independent risk factors for the 
development of neovascular AMD (Bressler et al. 1990). These may be seen 
clinically as focal clumping of pigment or small localized areas of atrophy 
respectively at the macular region (Figures 1.4a,b). Smiddy and Fine (1984) also 
demonstrated a statistically significant association between focal hyperpigmentation 
of the RPE and subretinal neovascularisation. An association of confluent drusen 
with subretinal neovascularisation was implicated to a lesser degree. An increased 
risk ratio for smoking and pigmentary abnormalities has also recently been reported 
(Mitchell et al. 2000), consistent with evidence that cigarette smoking is a significant 
risk factor for AMD. 
Histopathology studies show that degenerative pigmentary changes (Figure 1.5) have 
been found to be associated with clinically unsuspected subretinal neovascularisation 
(Sarks 1973). An ~xtensive histological study failed to find evidence that drusen 
predispose to subretinal neovascularisation, and indicated that eyes most prone to 
neovascularisation were those with a coarse pigmentary disturbance associated with 
a "basal linear deposit" (BlinD) beneath the RPE (Sarks 1976). However, a 
subsequent report noted that new vessels were commonly associated with serous 
drusen (Sarks 1980). 
1.7.2 Late AMD 
1. 7 .2.1 Exudative AMD 
The hallmark of exudative AMD is the growth of subretinal choroidal 
neovascularisation which compromises the outer BRB, resulting in exudation into the 
subretinal space of the macular and subsequent loss of photoreceptor function. 
Choroidal neovascular membranes may be subclassified into two main clinical types, 
as defined by fluorescein angiography: classic and occult and lesions may be a 
mixture of both. The minority of cases, approximately 15%, present with classic 
choroidal neovascularisation that occurs as a discrete elevation of the RPE, 
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Figure 1.6 Choroidal neovascular membrane in exudative AMD with extensive 
subretinal haemorrhage and exudation (courtesy ofProfF. Billson and Dr G. Painter) 
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commonly associated with subretinal exudation, haemorrhage and lipid deposition 
(Figure 1.6). Fluorescein angiography reveals a well-defmed area of early vascular 
hyperfluorescence with progressive leakage at later phases. The majority of recently 
diagnosed cases, more than 85%, present as occult choroidal neovascularisation, 
which may be seen clinically as a fibrovascular serous pigment epithelial detachment 
(PED) or as late-phase leakage of undetermined source on angiography. The clinical 
appearance of occult neovascularisation reflects the vascular growth pattern, the 
effect of the overlying RPE (Lafaut et al. 2000) and exudation when present. It is 
estimated that between 40 and 60% of all exudative AMD cases will develop 
predominantly classic lesions as the disease progresses (Freund et al. 1993; Yannuzzi 
et al. 1997). A recent review has detected vascular defects in AMD patients, 
suggesting that perfusion defects in the choroid account for some of the 
physiological and pathological changes observed in both exudative and nonexudative 
AMD (Harris et al. 1999). Histological studies of exudative AMD have also 
described choroidal disease involving primary degenerative changes in the 
choriocapillaris and Bruch's membrane and secondary alterations in the RPE and 
retina (Gass 1967). 
Subretinal neovascular membranes have also been classified as Type 1 or Type 2 
based on their pathological and clinical features (Gass 1967). Type 1 is characterized 
by neovascularisation within Bruch's membrane in the sub-RPE space. This type of 
neovascularisation features a broad expanse of the inner portion of Bruch's 
membrane, where the RPE is abnormally oriented or absent. Type 2 
neovascularisation occurs in the subretinal space and generally features only a small 
defect, where there is abnormal orientation or absence of the RPE. Type 1 
neovascularisation is more characteristic of AMD, whilst Type 2 neovascularisation 
is often found in ocular histoplasmosis (Grossniklaus and Gass 1998). Subsequent 
progression of choroidal neovascularisation leads to the evolution of a fibrovascular 
disciform scar (Figure 1.7), with destruction of photoreceptors, Bruch's membrane 
and the RPE (Figures 1.8a,b ). 
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Figure 1. 7 Extensive disciform scar involving the macula in a patient 
with late stage exudative AMD (courtesy of Prof F. Billson and Dr G. 
Painter). 
Figure 1.8a Semithin section showing established disciform scar 
(DS) on Bruch' s membrane (BM) with overlying retinal pigment 
abnormalities (RPE) (courtesy of Dr P. Penfold) 
~ 
Figure 1.8b Semithin section demonstrating subfoveal choroidal 
neovascularisation (CNV) with subretinal exudation, RPE 
abnormalities (PD) and disorganization of photoreceptor inner and 
outer segments (IS/OS) (courtesy of Dr P. Penfold and Dr J. Provis). 
Figure 1.9a Fundus photograph showing macular geographic atrophy 
(courtesy of Prof F. Billson and Dr G. Painter). 
Figure 1.9b Post-mortem eyecup photograph showing geographic 
atrophy at the macular of a donor AMD specimen. 
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1. 7 .2.2 Atrophic AMD 
Atrophic AMD is characterized by geographic (areolar) chorioretinal atrophy which 
is seen clinically as one or more well-delineated areas of atrophy of the RPE (Figure 
1.9). Histopathological studies indicate that atrophic AMD involves loss of the RPE 
component of the BRB at the macula, in the absence of clinical evidence of 
exudation. The atrophic lesion is associated with choroidal atrophy, involution of the 
RPE is directly, but not always immediately, associated with involution of the 
adjacent photoreceptors and outer retinal layers (Figure 1.1 0) (Penfold et al. 1986; 
Bressler et al. 1988; Tso 1989). Accumulation of pigment clumps at the edge of the 
area of atrophy is a typical feature of atrophic AMD (Sarks 1976; Penfold et al. 
1986). This phenomenon has recently been investigated clinically by Holz and 
colleagues (1999), who suggested that increased autofluorescence observed 
surrounding the GA in eyes with AMD, may reflect variable forms of reactive 
changes in the RPE cells. Recent studies have suggested RPE autofluorescence 
detected in vivo by scanning laser ophthalmoscopy may add helpful prognostic 
information for patients with AMD and appears to reflect signals from lipofuscin in 
the RPE (von Ruckmann et al. 1995; Bird 2003). Examples of GA and 
neovascularisatimi occurring in fellow eyes of the same individual and sometimes in 
the same eye have been reported (Green and Key 1977). Whilst atrophy of the RPE 
may result from the formation of avascular fibrous tissue (Sarks 1976) in 
combination with disciform degeneration (Green and Key 1977), atrophy of the RPE 
may also occur independently of the fibrovascular lesion. However, it has also been 
suggested that atrophic AMD may diminish the risk of choroidal new vessels in 
conjunction with narrowing and obliteration of the choriocapillaris (Bressler et al. 
1988). Experimental studies have more recently demonstrated reduced choroidal 
blood flow in non-exudative AMD caused by a decrease in choroidal blood volume 
(Grunwald et al. 1998a,b). 
1.8 AMD: PATHOGENESIS 
1.8.1 Immunity and AMD 
Increasingly, evidence from independent studies has demonstrated that the 
pathogenesis of AMD involves immunological and inflammatory processes, 
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Figure 1.10 Semithin section at edge of geographic atrophy lesion 
showing gliosis (G) along Bruch' s Membrane, disruption ofRPE and 
separation of photoreceptor inner and outer segments (IS/OS) (courtesy of Dr 
P. Penfold and Dr J. Provis) 
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including BRB compromise, and both cell-mediated and humoral immunity (Penfold 
et al. 1987; Penfold et al. 1990; Gurne et al. 1991; Penfold et al. 2001; Anderson et 
al. 2002; Bird 2003). Early publications demonstrated an appreciation of 
immunological processes in AMD, reporting that epithelioid cells, lymphocytes and 
choroidal infiltrates of leukocytes were associated with disciform macular 
degeneration (Paull927; reviewed Penfold et al. 2001). 
1.8.1.1 Humoral Immunity 
The presence of anti-retinal autoantibodies has been reported in association with a 
number of ocular pathologies (Dumonde et al. 1982; Heckenlively et al. 1996) 
including AMD (Tso 1989; Penfold et al. 1990). These studies demonstrated 
Autoantibodies with specificity for retinal tissue have been found in sera from 
patients with AMD, including observation of five different staining patterns (Tso 
1989; Penfold et al. 1990). Many sera produced patterns of labelling on human retina 
identical to that observed using an anti-OF AP antibody, an established marker of 
retinal astrocytes. The results indicate that the formation of anti -astrocyte 
autoantibodies may be an early feature of the pathogenesis of AMD, particularly in 
patients with pignientary disturbance (Penfold et al. 1990). Subsequently, antibodies 
against retinal proteins of various molecular weights have been detected by Western 
immunob1ot analysis in AMD patients (Chen et al. 1993). Similarly, Gurne et al 
(1991) detected antibodies immunoreactive with normal human retinal proteins, also 
by Western immunoblot analysis, in the sera of30 patients with AMD. However, it is 
not clear whether these autoantibodies play a direct role in the aetiology of AMD or 
represent a secondary response to retinal damage. 
1.8.1.2 Other Humoral Factors 
Studies demonstrating the association of other humoral factors with AMD have been 
consistent with the understanding that there is an inflammatory aspect to the 
pathogenesis of the disease. Acute phase proteins, including ceruloplasmin, 
fibrinogen and C-reactive protein, are a heterogeneous group of plasma proteins 
which alter their blood concentration in association with acute and chronic 
inflammation. An earlier study suggested relationship between serum ceruloplasmin 
and the tissue alterations associated with macular degeneration (Newsome et al. 
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1986). Subsequently, profiles of a variety of serum constituents, including 
immunoglobulins, alpha and beta globulins were examined in AMD patients. The 
results indicated a higher incidence of serum abnormalities, particularly involving 
alpha-2 globulin, in patients with RPE pigmentary disturbance (Penfold et al. 1990). 
A more recent study found an association between plasma fibrinogen levels and late 
AMD (Smith et al. 1998). 
Other work has been conducted on peptide and lipid mediators of the acute 
inflammatory response which appear to enhance adherence of circulating neutrophils 
to the microvascular endothelium (Tonnesen et al. 1989). Elimination of high 
molecular weight proteins and lipoproteins from the blood of AMD patients has been 
shown, in a randomised trial, to improve visual function (Widder et al. 1999). The 
deposition of phospholipids also may induce an inflammatory reaction resulting in 
choroidal neovascularisation (Pauleikhoff 1992). As indicated previously, it has also 
been suggested that locally derived vitronectin, complement and immunoglobulin 
components of drusen constitute a chronic inflammatory stimulus which leads to the 
binding of choroidally extravasated proteins into drusen (Anderson et al. 1999). 
1.8.2 Inflammation and AMD 
1.8.2.1 Chronic Inflammation 
Several studies have observed chronic inflammatory cells, particularly macrophages, 
in excised neovascular membranes from patients with AMD (Lopez et al. 1991; 
Gehrs et al. 1992; Seregard et al. 1994). additionally, macrophages have been 
observed in neovascular membranes associated with a variety of syndromes 
including ocular histoplasmosis (Saxe et al. 1993; Thomas et al. 1993; Oh et al. 
1999). Multinucleated giant cells, epithelioid cells and MPS cells are typical features 
of granulomatous inflammation and a number studies indicate a role for these c~lls in 
the pathogenesis of AMD (Penfold et al. 1985,1986; Pavan and Margo 1996; Wu et 
al. 1996). Penfold et a1 (1986) reported the involvement of chronic inflammatory 
cells in both the atrophic and exudative forms of AMD at the light and electron 
microscope level. Multinucleated giant cells appear to participate in the breakdown 
of Bruch's membrane and may provide an angiogenic stimulus for choroidal 
neovascularisation in AMD (Killingsworth and Sarks 1982; Penfold et al. 1985; 
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Wolter and Till 1989; Dastgheib and Green 1994; Sarks et al. 1997). Subretinal 
choroidal idiopathic membranes have similar morphologic features to membranes in 
AMD. Pavan and Margo (1996) reported histopathologic examination of a surgically 
excised membrane, showing a well-circumscribed granuloma containing 
eosinophils, suggesting the possibility of subretinal granulomatous inflammation. 
Multinucleate giant cells have also been demonstrated in surgically excised 
neovascular AMD membranes (Hutchinson et al. 1993). Multinucleated giant cells 
have been reported to derive from macrophages or endogenous microglia (Dickson 
1986). 
1.8.2.2 Macrophages 
Macrophages have been shown to play a role in inflammatory angiogenesis and 
normal vasculogenesis (Penfold et al. 1990; Sunderkotter et al. 1994). Prominent 
aggregations of lymphocytes in the subadjacent choroid of a disciform lesion have 
also been reported (Green and Key 1977). Penfold et al (1984) studied AMD 
specimens histologically to provide details of the role of immunocompetent cells in 
early, intermediate. and late stages of the disease. Histological analyses of the 
frequency anc;J.. d}stribution of inflammatory cellular infiltrates in AMD specimens 
also indicated the involvement of MPS cells, fibroblasts, and leukocytes including 
mast cells in neovascularisation, atrophy of the RPE and the breakdown of Bruch's 
membrane, suggesting that AMD has a chronic inflammatory component (Penfold et 
al. 1985). Ultrastructural features of subretinal neovascularisation associated with 
AMD confirmed the choroidal origin of new vessels and revealed a relationship 
between leukocytes and neovascular structures. These observations suggested that 
leukocytes are involved in the promotion of n'eovascular proliferation and exudation 
from new vessels (Penfold et al. 1987). The release of growth factors and cytokines 
such as vascular endothelial growth factor (VEGF) (Otani et al. 1999), IL-l~ and 
TNF-a. (Oh et al. 1999) from macrophages, may influence each phase of the 
angiogenic process (Sunderkotter et al. 1994). 
The process of neutrophil adhesion to, and migration through the microvascular 
endothelium, an early event in the induc_tion of'an acute inflammatory response, has 
been attributed to the generation of extravascular chemoattractants (Tonnesen et al. 
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1989). Wide-banded collagen appears to be a stimulus to inflammation and has been 
observed to be engulfed by macrophages (Loeffler and Lee 1986). Wide-banded 
collagen, phagocytosed by macrophages, has also been described associated with 
AMD lesions both above and below Bruch's membrane (Penfold et al. 1985). 
Further, it has been suggested that long spacing collagen in AMD eyes may be 
selectively internalised by macrophages (van der Schaft et al. 1993). The widespread 
accumulation of phospholipid-containing membranes, together with the focal 
concentration of lipid in hard drusen, may also attract macrophages (Killingsworth et 
al. 1990). 
1.8.2.3 Role of Microglia in Inflammation 
Microglia in the human retina have been shown to become activated in response to 
retinal pathologies including diabetes and glaucoma (Yuan and Neufeld 2001; Chen 
et al. 2002; Gardner et al. 2002). Pathological human retinae have been studied in 
order to investigate migration, and other responses of retinal microglia. Early studies 
described the different morphological features of activated retinal microglia using the 
del Hortega silver c~bonate stain (Vrabec 1975). More recently, the antigenic and 
morphologic features of microglial and vascular elements have been investigated in 
, . 
the neural retina from _eyes with AMD (Penfold et at. 1997). An increase in the 
proportion of the retina expressing MHC-II immunoreactivity was observed in age-
matched retinae compared with that seen in normal retinae, with hypertrophy of 
retinal microglia also apparent. In addition, an increase in MHC-11 immunoreactivity 
on vascular elements and morphological changes in microglia was associated with 
incipient AMD (Penfold et al .. 1997). lmll}unological responses in retinal microglia 
and vascular elements appeared to be related to early pathogenetic changes in the 
RPE and drusen formation (Penfold et al. 199'V. The exact nature of the signals 
which initially provoke choroidal neovascularisation has not been deflned, although 
immune mediation of neovascularisation by both choroidal-derived leukocytes and 
retinal microglia remain significant possibilities (Frade and Barde 1998; Minghetti 
and Levi 1998; Roque et al. 1999). More recent evidence supports findings that 
intracellular and extracellular proteolytic enzymes secreted from microglia, including 
cathepsin E, cathepsin S and other matrix metalloproteases, may act as mediators of 
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inflammation and tissue degradation through processing of pro-inflammatory 
cytokines (Nakanishi 2003). 
Evidence of vascular compromise in neovascular AMD has been recently 
documented (Harris et al. 1999). Whilst the signals which provoke 
neovascularisation in AMD remain to be defined, it is recognised that macrophages 
are particularly sensitive to oxygen tension (Knighton et al. 1983; Lewis et al. 1999) 
and microglial macrophages therefore may play a primary role in mediating 
physiological responses of the retina to reduced oxygen tension. 
1.8.2.4 Growth Factors and Cytokines 
Recent studies have shown that growth factors play important roles in various retinal 
diseases (Tanihara et al. 1997; reviewed Schlingemann). Microglia and cells of the 
macrophage/ monocyte series are capable of secreting a diverse range of growth 
factors including VEGF and TGF~ (Minghetti and Levi 1998; Minghetti et al. 1999; 
Das and McGuire 2003; Schlingemann 2004). Growth factors including VEGF, 
PDGF, FGF-1 and -J. and TGF~, are not expressed at detectable levels in normal 
/ . . 
RPE (Frank 1999) but have been reported to be prominent in RPE, neural retina, 
endothelial cells, macrophages and fibroblasts in neovascular membranes (Amin et 
al. 1994; Reddy et al. 1995; Kvanta et ~· 1996; Kliffen et al. 1997; Das and McGuire 
2003; Schlingemann 2004). More recently, VEGF and other angiogenic factors 
including endothelial-specific receptor kinases (e.g. Tie2 and its ligand, Ang2) have 
also been observed to be expressed in a variety of cell types in choroidal neovascular 
membranes (Otani et al. 1999; Das and McGuire 2003; Martinet al. 2004). 
Microglia and astrocytes in neural tissue synthesize and secrete pro-inflammatory 
cytokines including IL-l~, IL-6 and 1NF-a (Minghetti et al. 1999; Cross and 
Woodroofe 2001). These cytokines have regulatory functions in immune responses, 
inflammation and wound healing. IL-l~ stimulates the production of IL-6, and these 
cytokines contribute synergistically to acute pathologic changes. The pro-
inflammatory effects of IL-l~ and 1NF-a on the BRB have been demonstrated to 
include permeability changes involving microglia and Muller cells (Claudio et al. 
1994). Synthesis of other cytokines such as IL-10 which has important anti-
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inflammatory properties can be induced in microglia in vitro (Lee et al. 2002). The 
mechanism(s) of IL-10 modulation during neuroinflammation are not fully 
understood (Chabot et al. 1999), but may involve high-affinity ll-1 0 receptors acting 
• 
via paracrine and autocrine interactions in astrocytes and microglia (Ledeboer et al. 
2002). The precise role of growth factors in incipient, exudative and non-exudative 
AMD remains to be fully established 
1.9 AMD: TREATMENT 
Currently there are limited treatment options for most forms of AMD, however new 
therapies are being investigated and developed for both exudative and non-exudative 
AMD. 
1.9.1 Treatment of Non-exudative Macular 
Degeneration 
Recent large randomised controlled trials have demonstrated the benefit of 
micronutrients in d~reasing the risk of disease progression in some p<;ttients with 
non-exudative AMD. The Age--Related Eye Disease Study (AREDS) (Age-Related 
Eye Disease Study Research 2001) randol!llY assigned AMD patients to receive daily 
oral tablets containing antioxidants vitamin C, vitamin E, beta carotene, zinc and 
copper or placebo. Those patients with extensive intermediate size drusen, at least 
one large druse, noncentral GA in one or both eyes, or advanced AMD or vision loss 
due to AMD in one eye who took the antioxidants and zinc combination above ha a 
moderate reduction in vision loss due to AMD and reduced odds of developing 
advanced AMD (Age-Related Eye Disease Study Research 2001 ). 
Ongoing studies are investigating the merits of argon laser treatment to induce the 
• 
regression of drusen. Disappearance of drusen spontaneously and in areas adjacent to 
laser photocoagulation scars was first noted by Gass (1973), with subsequent reports 
confirming these observations. Photocoagulation-induced drusen regression might 
prevent patients with drusen from developing exudative maculopathy (Abdelsalam et 
al. 1999). The exact mechanism for spontaneous drusen regression is Wlknown 
however probably involves RPE atrophy. It has been proposed that laser treatment 
<. 
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may prevent development of exudative maculopathy by inducing dissolution of 
BlinD leaving a residuum ofBlamD. Sarks and co-workers (1997) proposed that this 
may in tum will eliminate the potential cleavage plane between the RPE basement 
membrane and inner collagenous layer of Bruch's membrane through which 
choroidal new vessels grow, thus retarding the growth of these vessels. Early studies 
of laser therapy showed benefits of improved visual acuity and contrast sensitivity at 
one year, associated with drusen reduction (Ho et al. 1999). However, more recent 
follow-up studies have not shown any significant benefit, with an increased earlier 
incidence of non-vision threatening choroidal neovascularisation (Choroidal 
Neovascularization Prevention Trial Research Group 2003). 
1.9.2 Treatment of Exudative AMD 
1.9.2.1 Laser and Surgical Treatment for Exudative AMD 
Many forms of treatment are being evaluated for the treatment of exudative AMD. 
Two therapies have been shown in multicentre, randomised controlled trials to be 
effective for the treatment of exudative AMD: standard thermal argon laser 
photocoagulation and photodynamic therapy (PDn. The Macular Photocoagulation 
" Study (Macular- Photocoagulation Study Group 1991) evaluated the safety and 
efficacy of thermal laser photocoagulation for the treatment of various forms of 
choroidal neovascularisation including extrafoveal, juxtafoveal and subfoveal 
choroidal neovascularisation. This study demonstrated that thermal laser 
photocoagulation of extrafoveal and juxtafoveal classic choroidal neovascularisation 
reduces the risk of severe visual loss (Macular Photocoagulation Study Group 1991; 
Macular Photocoagulation Study Group 1994) However the results for subfoveal 
lesions were less clear. Two major drawbacks included irreversible collateral damage 
to the macula and a high recurrence rate (Macular Photocoagulation Study Group 
1993). 
PDT was initially reported to be moderately effective in limiting progressive visual 
loss in patients with predominantly classic or purely occult subfoveal choroidal 
neovascularisation (Treatment of age-related macular degeneration with 
photodynamic therapy (TAP) Study Group 1999; Verteporfin In Photodynamic 
• 
Therapy Study Group 2001 ). Intravenous injection of a photoactive dye selectively 
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taken up by the choroidal neovascularisation (V erteporfin) is followed by infrared 
laser treatment to the macular region, resulting in less dramatic collateral central 
visual loss. However, this mode of treatment requires multiple treatments over many 
months, is currently very expensive and only rarely offers modest visual restoration 
(Sternberg and Lewis, 2004). Other treatment modalities currently under evaluation 
for the management of choroidal neovascularisation include submacular surgery 
involving surgical removal of choroidal new vessels beneath the retina (Submacular 
Surgery Trials Group 2000) and macular translocation, where the macular 
sensorineural retina is transposed over a new area of healthy choroid (Chang et al. 
2003). 
1.9.2.2 lntravitreal Corticosteroid Treatment 
Recently, there has been significant interest in the use of intravitreal administration 
of anti-inflammatory and anti-angiogenic agents for the treatment of ocular 
conditions including exudative AMD, cystoid macular oedema, diabetic retinopathy 
and posterior uveitis. Intravitreal administration of anti-inflammatory corticosteroids 
including TA is currently under investigation as treatment for exudative AMD. 
Corticosteroids afe commonly used to treat inflammatory eye diseases (JeiUlings et 
al. 1988; Riordan-Eva and Lightman 1994). This class of hormone is known to exert 
anti-inflammatory effects upon immune function in multiple ways. Recent interest in 
the literature has focused on the effects of corticosteroids on glial cells, via control of 
expression of genes coding for growth factors, growth factor receptors, cytokines and 
neurotransmitters (Jordan 1999; Vardimon et al. 1999). In addition, corticosteroids 
have been shown to be potent inhibitors of microglial proliferation (Ganter et al. 
1992), a mechanism which may explain the observed effects of corticosteroids on 
microglial markers and populations in AMD retinae. 
Corticosteroids display differential capacities to regulate inflammation and tissue 
oedema (K.atzung 1987). Steroid receptors are ligand-dependent intracellular proteins 
that regulate transcription of specific genes ~Y binding to DNA following activation 
by the appropriate hormone. All normal mammalian tissues examined to date have 
been shown to contain glucocorticoid receptors (GR). Mineralocorticoid receptors 
(MR) regulate ion channels in cell membranes; in the retina, MR immunoreactivity 
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has been observed in Miiller cells, external and internal limiting membranes, the 
vitreous base lining and in the RPE (Mirshahi et al. 1997). The rationale for the use 
of the anti-inflammatory corticosteroids has been derived from observations of the 
involvement of retinal oedema and immunity in the pathogenesis of exudative AMD, 
and from studies hsowing the efficacy anti-inflammatory corticosteroids in animal 
models of inflammatory subretinal neovascularisation and in clinical studies. 
The anti-inflammatory effects of corticosteroids are thought to depend on the same 
mechanisms through which they exert physiological actions (Di Rosa et al. 1985). 
Early studies indicated that glucocorticoids decreased the number of macrophages in 
wounds to approximately one-third of that in controls (Leibovitch and Ross 1975). 
Glucocorticoids can suppress the activity of monocytes and macrophages including 
the release of tumour necrosis factor-a. (TNF-a.) and this is likely to contribute to the 
efficacy of glucocorticoids in some inflammatory diseases, such as rheumatoid 
arthritis. Monocytes also release soluble receptors for TNF-a., which can modulate 
TNF-a bioactivity. Interactions between cytokines and glucocorticoids may be 
antagonistic or additive on IL-l and 1NF-a. activity. Their capacity to stimulate 
release of IL-1RA may contribute to the anti-inflammatory potential of IL-4 and in 
monocyte/macrophage-mediated disease '(Joyce et al. 1996). A significant 
mechanism of action of corticosteroids is the"ir ability to inhibit pro-inflammatory 
cytokines but to enhance the anti-inflammatory cytokine IL-l 0 (reviewed Brattsand 
and Linden, 1996; Brunetti et al. 2002; Mozo et al. 2004). IL-10 and corticosteroids 
may act synergistically, allowing the use of lower doses of both agents in regulating 
chronic inflammation. 
In microglial cell cultures dexamethasone has been shown to block the release of 
TNF-a and IL-6 (Chao et al. 1992). In situ histopathological analyses of fellow eyes 
of a patient with exudative AMD showed that intravitreal corticosteroid 
administration diminished microglial/ macrophage numbers associated with reduced 
retinal oedema (Penfold et al. 2001) (see C~apter 4). Recent studies have suggested 
that glia actively modulate neural tissue function throughout life via the action of 
steroids. Muller cells are the most abundant retinal cell and are important in 
maintaining ion balance and recycling excitatory neurotransmitters. Glia cells 
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possess steroid receptors and may be direct targets for steroid hormones. The 
promoter regions of glial-specific genes such as GF AP and glutamine synthetase 
have been shown to contain hormone-responsive elements (Jordan 1999). 
VEGF is a specific mitogen for vascular endothelial cells and enhances vascular 
permeability. The capacity of corticosteroids to reduce oedema or to prevent new 
blood vessel formation may be attributed, at least in part to the ability of these agents 
to abolish the expression of VEGF (Nauck et al. 1998). Currently, clinical trials are 
underway to investigate the potential benefits of anti-VEGF aptamers in the 
treatment of exudative AMD. Phase II trials have shown the possible benefit of 
repeated intravitreal injection in inhibition of neovascularisation (Eyetech Study 
2003). Vasopermeability effects may also be mediated by mast cells via the release 
of histamine (Church and Levi-Schaffer 1997). Animal models of oedema mediated 
by histamine and 5-HT release have shown to be suppressed by dexamethasone (Di 
Rosa et al. 1985). Ultrastructural studies have also reported increased numbers of 
mast cells in the choroid of AMD specimens (Penfold et al. 1984) . 
Triamcinolone acetonide (TA) is a synthetic corticosteroid with marked anti-
. . . 
inflammatory action, often used in the treatment of inflammatory musculoskeletal 
disorders. Early studies showed that intravitreal administration of T A reduced the 
incidence of retinal neovascularisation in rabbits (Tano et al. 1980; Chandler et al. 
1985), as well as laser-induced choroidal neovascularisation in primates (Ishibashi et 
al. 1985). In a rabbit model of preretinal neovascularisation, TA effectively inhibited 
new vessel growth in treated eyes, suggesting that intravitreal T A might be effective 
in inhibiting new vessel growth in patients with inflammatory retinal 
neovascularisation, such as associated with sarcoidosis or other uveitic syndromes 
(Antoszyk et al. 1993). 
Preliminary clinical studies indicated that T A has the capacity to promote resorption 
of subretinal exudation (Penfold et al. 1995; Danis et al. 2000; reviewed Jonas et al. 
2004). Posterior sub-Tenon's triamcinolone injection has also been reported to 
significantly decrease cystoid macular oedema with a corresponding increase in 
visual acuity, in patients with posterior uveitis (Tanner et al. 1998; Young et al. 
2001), or Vogt-Koyanagi-Harada syndrome (Rutzen et al. 1995). TA has further 
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been shown to inhibit fluorescein leakage in a model of preretinal neovascularisation 
(Antoszyk et al. 1993). Recent studies indicate that TA has the capacity to modulate 
epithelial cell resistance and ICAM-1 expression in vitro (Penfold et al. 2000; 
Penfold et al. 2002). The use of intravitreal TA for subretinal neovascularisation has 
been investigated in a number of clinical studies (Penfold et al. 1995; Danis et al. 
2000; Jonas et al. 2003, 2004), including as an adjunctive treatment to PDT 
(Rechtman et al. 2004). Results from these studies have shown promise in reducing 
the rate of visual loss for AMD patients without significant complications. 
Intravitreal TA injection is currently undergoing further study to assess its potential 
for application in the management of AMD, either as a primary and/or adjunctive 
therapy. 
1.10 Hypothesis and Aims 
As discussed in this review, the aetiology of AMD remains poorly understood, 
although the pathogenesis of the disease has been shown to involve both 
immunological and inflammatory processes in the neural retina, RPE and underlying 
choroidal circulati~n. Recent studies have indicated a role for microglia - the 
resident immunocompetent cells of the retina - in the pathogenesis of AMD. 
Compromise of the BRB at the level of the RPE is also thought to be a critical event 
leading to subretinal choroidal neovascularisation in the exudative form of AMD. 
The involvement of choroidal vasculature, including choroidal leukocytes and the 
angiogenic signals to neovascularisation is also under investigation. 
Quantitative image analysis techniques based on immunohistochemistry have been 
found to be useful in investigating the role of specific proteins in the pathogenesis of 
disease, whilst also allowing simultaneous study of morphological changes in normal 
and pathological tissue. Leukocyte Common Antigen (CD45) is a cell surface 
glycoprotein found exclusively on leukocytes and is a specific microglial marker; 
CD45 is known to be involved in signal transduction and lymphocyte regulation. The 
exclusivity and specificity of CD45 to leukocyte lineage cells, including microglia 
and choroidal leukocytes, together with image analysis technology provides a 
rationale for the measurement of the inflammatory cell content of retinal tissue. 
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This thesis aims to test the hypothesis that retinal microglia, choroidal leukocytes and 
the immunofunctional protein CD45 are involved in the pathogenesis of AMD. 
Specifically these studies aim: 
• To develop quantitative immunohistochemical techniques based on 
immunofluorescence, scanning laser confocal microscopy and digital image 
analysis to quantify the inflammatory cell content of ocular tissue. CD45 
antigen expression will be used to define leukocyte populations. 
• To compare the quantitative expression of CD45 on retinal microglia and 
choroidal leukocytes in normal, AMD and subtypes of AMD retinae. 
• To observe differences in retinal microglial morphology between AMD· 
affected and normal retinae, including differences between the subtypes of 
AMD. 
• To measure the in situ effect of anti·inflammatory corticosteroids on 
microglial populations, choroidal leukocytes and expression of inflammatory 
proteins in a patient with exudative AMD. 
·. 
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CHAPTER2 
A Rationale for Quantitative Immunofluorescence, 
Confocal Microscopy and Digital Image Analysis. 
< 
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2.1 INTRODUCTION 
Immunohistochemistry is an investigative immunological technique that recognizes 
constituents of tissues as antigens in situ by means of corresponding colour-tagged 
antibodies (Brandtzaeg 1998). It is classically used to localize microscopic structures 
such as cells or granules by their antibodywantigen conjugation reactions or to 
demonstrate that specific immunoreactivity is associated with a particular 
microscopic component (McBride 1995). Comparison of in situ mapping of 
functional markers in normal and pathological specimens represents a useful tool 
which can provide information about disease pathogenesis and the establishment of 
etiology (Brandtzaeg 1998). 
Quantitative immunohistochemistry involves the extraction of data from the 
distribution and amount of antibody labelling in tissue specimens. 
Immunohistochemistry in conjunction with image analysis systems can measure 
changes in antigen localization either by direct comparison of numbers of labelled 
elements or by quantification of antibody concentration. Immunohistochemical 
techniques have . . the added advantage of allowing simultaneous assessment of 
morphology and topographical relationships of structures within a tissue, unlike other 
purely quantitative techniques such as radioimmunoassay (RIA) (McBride 1995). 
Whilst other molecular techniques can often measure more precisely total tissue 
concentrations of proteins or messenger RNA, immunohistochemistry may allow 
more accurate assessment of the local concentration of an antigen in a complex tissue 
which is often more difficult, especially if the antigen is not evenly distributed 
(McBride 1995). 
Quantitative immunohistochemical techniques have been previously used 
successfully in the investigation of retinal and neural pathology (Liew et al. 1994; 
Penfold et al. 1997; Ruifrok 1997; Wu et al. 1997) . Whilst these studies have 
utilised older established techniques using light microscopy and CCD video cameras, 
recent advances in immunofluorescence histochemistry, scanning laser confocal light 
microscopy, digital image analysis and the availability of more powerful personal 
computers have enabled potential further benefits of this technique to be realised. 
Brandtzaeg (1998) noted that there has been and exponential rise in quantitative 
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Figure 2.1 Three-step indirect immunofluorescent technique, showing 
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immunohistochemical publications in the literature over the last decade (Brandtzaeg 
1998), reflecting an increasing acceptance of the validity and utility of this technique 
over a diverse range of biomedical applications (Terenghi et al. 1991; Gentleman et 
al. 1992) 
The rationale for the development of a methodology for quantitative 
immunohistochemistry of immunofunctional markers in normal and pathological 
retinae is based upon the advantages of recent developments in immunofluorescence, 
confocal microscopy and computerised digital image analysis. Many of these relate 
to the ability for increased accuracy of estimation, improved standardisation, the use 
of efficient, modem technology and the wider availability of affordable, user-friendly 
image analysis programs based on personal computers. 
2.2 FLUORESCENCE IMMUNOIDSTOCHEMISTRY 
Immunohistochemistry using fluorescence involves the coupling of fluorescent dyes 
such as fluorescein to antibodies without destroying their ~pecificity and consequent 
combination with antigen present in a tissue section. Conjugated antibody-antigen 
complexes can then be visualised by fluorescent microscopy (Roitt 1997). Direct 
immunofluorescence involves application of a fluorochrome-coupled primary 
antibody directly to the tissue antigen substrate (Figure 2.1). When viewed under an 
epifluorescent microscope, only the cells or components expressing the target antigen 
will be brightly stained. Indirect immunofluorescence involves the use of 
intermediate secondary immunoglobulins targeted against the primary antibody and a 
fluorochrome visualisation molecule. Secondary antibodies and fluorochromes can 
each be conjugated with molecules which have high affinity for other molecules e.g. 
biotin and avidin. advantages of this system include greater potential amplification of 
signal, increased flexibility with multiple primary and secondary systems, and 
increased sensitivity, however with the disadvantage of decreased specificity 
(Boenisch 1989; Roitt 1997) (Figure 2.1 ). 
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Figure 2.2 Principle of confocal microscopy showing epifluorescent 
rays from a focal point on a slide entering a photomultiplier, whereas 
rays from focal plane below slide fail to reach PMT. 
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2.3 CONFOCAL MICROSCOPY 
The principle of confocal imaging involves using a point light source to view an 
object while a point detector collects the reflected and scattered light (Boyde 1995). 
The scanning laser confocal microscope illuminates an object with a small, 
diffraction-limited spot from a focused laser beam and views the image with a 
spatially-restricted optical system so that signals emanating only from this spot are 
detected (Van Oostveldt and Bauwens 1990). As a result, image contrast and axial 
and lateral resolution are superior to that of conventional microscopes, but at the 
expense of field of view (Petran et al. 1968,1985; Sheppard 1993). 
Fluorescent-labelled tissue preparations are scanned by a stimulating laser in a raster 
pattern in a single, narrow focal plane within the tissue and the fluorescence emission 
is collected by a photomultiplier tube (PMT). Fluorescence from planes above and 
below the object plane fails to reach the PMT, maintaining sharpness of the image 
and eliminating out-of-focus noise (White et al. 1987). This contrasts with 
conventional epifluoresence methods~ where flare from other focal planes contributes 
to the image, degrading the overall image (Sheppard 1993). As a result, . individual 
. •. 
XY focal planes can be readily assessed quantitatively (Roitt 1997). Another optical 
advantage of the confocal imaging is that the effective point-spread function of the 
system is reduced, resulting in improved resolution of the fmal image (White et al. 
1987) (Figure 2.2) 
Confocal imaging also allows non-destructive optical sectioning of tissues with little 
degradation of the image quality of interior structures (White et al. 1987; Trogadis et 
al. 1995). A "Z-series" stack of serial optical slices can be assembled by scanning the 
tissue at regular depths. Thus, an "optical grid" of pre-determined dimensions can be 
superimposed over a tissue section and allow consistent comparison between 
• 
specimens (see Chapter 3, Figure 3.1). In addition, confocal microscopy ·of 
specimens incubated with multiple primary antibodies and different fluorochromes of 
different wavelength allows simultaneous multiple-labelling, ~d can be a useful 
technique in determining co-localisation of antigens. 
·. 
30 
Chapter 2: Quantitative Immunohistochemistry 
Viewing and storage of images involves emitted epifluorescent light collection by a 
photomultiplier tube (PMT) which converts the light intensity to electrical signals. 
The selected field is effectively digitized and represented on a screen as a bitmap 
image comprised of pixels (picture elements), each of a specific scaled intensity. 
Pixels of a 3-dimensional object in a Z-series of confocal slices are termed "voxels" 
(volume elements or volume pixels). Digitized images can then be readily imported 
into image processing and analysis programs for manipulation and data extraction. A 
series of optical sections can be rearranged to enable 3-dimensional reconstruction of 
the original specimen, giving an added advantage in morphological and 
topographical analysis (Verschure et al. 1994; Boyde 1995; Trogadis et al. -1995). 
2.4 QUANTITATIVE IMAGE ANALYSIS 
Image analysis involves the extraction of meaningful measurements from images 
(McBride 1995). In a histological context, it involves the production of quantitative 
information from image data (Wootton 1995). Quantitative approaches to 
immunohistochemistry can be divided into two main categories: those that involve 
the counting or- ·measuring of immunoreactive structures without regard to the 
intensity of the immunoreactivity and those that estimate or discriminate differences 
in the intensity of immunoreactivity (McBride 1995). 
2.4.1 Counting of Immunoreactive Structures 
The technique of counting labelled structures involves estimation of the number of 
immunostained structures and is based on specific underlying assumptions, including 
that all immunoreactive structures are stained and that the major experimental effect 
or difference is a change in the size and/or number of such structures. Stereology 
involves sampling principles that should be followed in order to achieve an unbiased 
estimate in quantification of 3-dimensional structures when their volumetric features 
have been reduced by sectioning (Browne et al. 1995). 
Specific considerations related to immunohistochemistry which may affect accurate 
labelling of epitopes include the "Bigbee effect" and discrimination of 
immunoreactive structures from background. Bigbee (1977) described an effect in 
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immunohistochemical labelling where if there are excessive epitopes, a 3-step 
indirect immunohistochemistry teclmique may not demonstrate immunoreactivity of 
all epitopes, as available sites on the secondary antibody may have been bound by 
primary antibody, leaving none to bind to the tertiary visualisation system (Figure 
2.3). Also, detection of labelled structures from background where the staining is 
faint or variation in staining intensity between individuals or between sections may 
present particular problems for identifying immunoreactive structures objectively 
(Sternberger and Sternberger 1986). 
2.4.2 Measurement of Immunoreactivity Intensity 
Quantitative measurements of immunoreactivity intensity may detect experimental 
differences not initially apparent to human observation, as the human visual system 
is a relatively poor densitometer, especially when comparing structures in different 
fields (McBride 1995). Microdensitometry is the direct measurement of optical 
density of immunostaining of microscopic structures and is regarded by some 
authors as the only truly quantitative method of estimating distribution of 
immunoreactivity among microscopic tissue compartments (McBride 1995). The 
. 
. . 
approach has been validated in a variety of studies (Benno et al. 1982; Gross and 
Rothfeld 1985; Peretti-Renucci et al. 1991; Mausset-Bonnefont et al. 2003; Wu et al. 
2003). Specific assumptions also ~pply in intensity measurements, as with counting 
measurements, including that the intensity of staining of a structure is directly related 
to the concentration of immunoreactive epitopes in that structure. A linear 
relationship between intensity of staining and immunoreactivity of epitopes is ideal, 
hence it is important to include dilutional standards and relevant controls in 
comparative experiments (McBride 1995; Springall et al. 1995) (see Appendix II). 
Potential factors which may compromise this relationship also include the Bigbee 
effect as well as steric hindrance. In steric hindrance, if epitopes are spaced more 
closely than the average diameter of the Fab fragment of an IgG molecule (approx 5-
1 Onm), antibody binding will be limited by the size of the immunoglobulin molecule 
rather than by the number of epitopes, resulting in loss of the direct relationship 
between epitope density and staining intensity (McBride 1995) (Figure 2.4). This 
consideration applies more importantly to indirect immunohistochemistry methods 
that are more susceptible to this effect, where there are second and third order 
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antibody-antigen conjugations, such as a biotin-avidin or peroxidase-antiperoxidase 
complex (Boenisch 1989). 
2.4.3 Previous Methods of Quantitative 
Immunohistochemistry using Transmission ~ight 
Microscopy 
Methods of quantitative immunohistochemistry that rely on conventional 
transmission light microscopy include immunoenzymatic reactions e.g. horseradish 
peroxidase or other antigen-antibody binding reactions e.g. silver-enhanced 
immunogold. Both these methods involve labelling structures with dark insoluble 
end-products which are then visualised by standard light field transmission 
microscopy (Boenisch 1989; Boenisch 1989). Image capture is usually by a video 
camera which digitizes the selected field for presentation on a video screen (Jones 
1999). In conventional light microscopy, each objective has a specific depth of field 
and consequently, selection of focal planes within a tissue specimen for 
quantification can be ~ighly user-dependent. Whilst random sampling of fields 
within a specimen is an important requirement to satisfy stereological rules, the 
fundamental parameters of each field, such·as the number and depth of focal planes 
taken should be standardised to allow more· accurate comparison between fields and 
specimens (Browne et al. 1995). Also, as the intensity of end-product staining is 
dependent on the intensity of light illuminating the field, illumination should also be 
kept at a uniform level. In addition, standard incandescent light sources usually are 
not evenly distributed over a whole field thus introducing further need for 
compensation against potential error (McBride 1995). Other potential errors of light 
microscopy quantitative immunohistochemistry include calibration of optical density 
measurements, where absorbance is related to optical density by an exponential 
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relationship, the Beer-Lambert law, rather than a direct linear relationship as found in 
fluorescence intensity (Jones 1999). 
2.4.4 Image Processing and Analysis 
Following image input into image analysis systems, the selected field is depicted as 
an array of values which represent the original picture (Wootton 1995). The original 
image is decomposed into small picture elements (pixels) and a value representing 
some characteristic of the image as each element is stored, hence defming two key 
parameters of the digital representation of an image: spatial resolution and pixel 
quantization (Ruifrok 1997; Jones 1999). Spatial resolution or the fineness of the 
mesh into which the image is divided is defined by the number of pixels within a 
given area. The second element is usually a quantization of the pixel, and for 
monochrome images is termed the "greyscale" (the number of shades of grey which 
represent the change from pure black to pure white). For colour images, the 
quantization level or greyscale equivalent takes into account the spectral properties 
of the image. Most monochrome images in histological work consist of an 8-bit 
greyscale (28 = 256) levels of grey from black to white, with an adequate spatial 
resolution of S1i'x 512 pixels. The human eye does not usually have the ability to 
detect more than 2561evels of grey (Wootton 1995). 
An important principle in quantitative image analysis of immunolabelled tissue is the 
ability to distinguish labelled components from unlabelled, background elements. 
Segmentation is the partitioning of an image into meaningful regions or separating 
regions that belong to an object from background in some special way (Wong 1995). 
Segmentation techniques can be categorized into two major groups: point dependent 
techniques and region dependent techniques. Point dependent techniques label pixels 
according to the greyscale of the individual pixels, and commonly used teclmiques 
include histogramming and thresholding. Region dependent teclmiques i~volve 
segmentation based on the properties of the regions e.g. Gaussian distribution of the 
greyscale or other context dependent information such as textures (Wong 1995; 
Jones 1999). Once the image has been segmented, objects of interest can then be 
measured to extract relevant data. Parameters such as number of objects, area of each 
object, mean greyscale value, perimeter and orientation can be recorded accurately, 
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then exported to a spreadsheet program for tabulation, graphing and statistical 
analysis. 
2.4.5 Rationale for the Development of a Quantitative 
Confocal Immunofluorescent Technique. 
Advantages in the use of a quantitative immunohistochemistry technique based upon 
epifluorescence, confocal microscopy and 'C.ligital image analysis include increased 
accuracy of estimation, improved standardisation, and the availability of affordable, 
modern, user-friendly image analysis programs for personal computers. 
In any quantitative image analysis method, errors may occur at each stage of 
processing however an ideal system can accurately distinguish differences between 
samples as a result of an induced experimental change or as a result of a pathological 
process. Methods to minimize errors include processing both normal and 
pathological specimen in identical ways (Springall et al. 1995), rigorous 
standardization of settings and including relevant conttols. 
Immunolabelling using direct or indirect immunofluorescence is a process that is less 
dependent on user variation. Incubation times for primary and secondary antibodies 
and for fluorochromes can be standardised reliably, unlike some methods such as the 
3,3'-Diaminobenzidine tetrahydrochloride (DAB) - peroxidase system where final 
chromophore reaction times and hence staining intensity may vary depending on 
rapidity of reaction progression and subsequent termination (Boenisch 1989a,b ). 
Although immunofluorescent techniques have many advantages, one main 
disadvantage is the bleaching or fading of fluorochromes. Whilst many modem 
fluorochromes are reasonably stable, prolonged exposure to illumination, inc~uding 
ambient light will eventually cause loss of intensity (Valnes and Brandtzaeg 1985). 
Differential photobleaching of specimens remains a problem in any comparative 
study, and can be minimised by stringent monitoring of light exposure time to each 
specimen, including preliminary viewing times. The use of anti-fade agents such as 
1,4-diazabicyclo[2.2.2]octane (DABCO) or paraphenylenediamine (PPD) in slide 
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mounting medium has also shown to minimize the effects of photo bleaching (V alnes 
and Brandtzaeg 1985; Yu et al. 1994; Trogadis et al. 1995) . 
Image capture by scanning laser confocal microscopy allows improved 
standardisation over conventional light microscopy techniques. Confocal images 
consist of optical sections of infinitely thin depth of field. The number and width of 
sections within an optical grid of confocal images can be pre-defined and thus remain 
standardized between specimens. This eliminates the necessity for the user to select 
(possibly varying) planes of focus under conventional light field microscopy 
techniques (Boyde 1995). Also, the confocal laser raster uniformly illuminates the 
specimen, unlike incandescent light sources which can vary in illumination across a 
given fteld. Many scanning laser confocal microscopes also have a function which 
monitors specific laser output, which can be adjusted to remain within acceptable 
limits. Other scanning parameters such as field size, resolution, scanning speed and 
photomultiplier gain can also be standardized by adjusting the settings at a specific 
level. Confocal microscopy also allows more· accurate and enhanced morphological 
and topographical analysis of microscopic structures. As a result of an infinitely thin 
depth of field,. topographical relationships of structures can be more accurately 
assessed and quantitatively measured (Boyde 1995; Mausset-Bonnefont et al. 2003; 
Ruifrok et al. 2003). Intracellular components previously hidden in conventional 
light microscopy immunohistochemistry techniques can now be visualized without 
interference from external boundaries, much as computerised tomography (CT) 
scanning allows detailed examination of internal body structures (Boyde 1995). 
The NIH Image software package (National Institute of Health, USA) is a public-
domain image processing and analysis package developed for Macintosh computer .. 
It has sophisticated particle analysis capability as well as 3-dimensional 
reconstruction functions. A stack of optical confocal sections stored in various digital 
formats including the TIFF (Tagged Image File Format, Adobe Systems, Silicon 
Graphics Systems) can be easily imported into NIH Image for processing. Arithmetic 
averages using an Image Math AVERAGE function can be derived from 
compressing the multiple layers into a single layer for particle analysis. This program 
also allows automated functions using a macro progranuning language, whereby a 
series of conunands can be listed together to streamline the data acquisition process 
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and to reduce time formatting individual functions. With ongoing developments, 
NIH Image is increasingly being utilised as a widely available, user-friendly, but still 
powerful image analysis tool (Mize 1994; Ruifrok 1997; Tanihara et al. 1997; Brown 
et al. 1998; Plantner et al. 1998; Sickenberg et al. 1999; Wu et al. 2003). 
In recent studies, authors have employed quantitative immunohistochemical 
techniques based upon fluorescence, confocal microscopy and image analysis for 
morphological and topographical characterisation of structures and investigation of 
pathogenetic mechanisms. These techniques have applications in the detection or 
monitoring of pathological processes which result in a morphological or- structural 
change, or a change in immunoreactivity of a particular antigen, (Springall et al. 
1995). 
[, Quantitative image analysis techniques have been employed in investigation of 
l neurotransmitter expression in neurodegenerative diseases (Trogadis et al. 1995; Wu , 
~ et al. 1997; Mausset-Bmmefont et al. 2003). Gentlemen et al. (1992) found 
[ differential levels of beta amyloid protein in different cortical grey matter of patients 
~ . 
with Alzheimer's disease using quantitative image analysis techniques. Similar 
methods have been used in studies of ocular diseases (Plantner et al. 1998; 
Sickenberg et al. 1999). McLeod et al (2002) used computer-assisted morphometric 
analysis to quantify changes in RPE and choriocapillaris in age-related macular 
degeneration eyes. Plantner et al (1998) have shown an increase in 
interphotoreceptor matrix gelatinase A (MMP-2) associated with AMD retinae using 
the NIH Image program and quantitative immunohistochemical techniques. Excised 
choroidal new vessels have also been examined using confocal microscopy and 
image analysis (Hashimoto and Harada 1999). In an investigation of microglia and 
dendritic cells, lectin histochemistry and image analysis were used to quantify the 
microglial response following an injection of N-methyl-D-aspartate (NMDA) into 
the sensorimotor cortex of rat brains (Acarin et al. 1997). Scanning laser confocal 
microscopy has also been used to morphologically and quantitatively assess 
Langerhans cells (Yu et al. 1994). 
In a similar fashion, there is a rationale for the utilisation of immunofluorescence, 
confocal microscopy and quantitative image analysis techniques to investigate 
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morphological changes and levels of expression of immunofunctional markers of 
retinal microglia and choroidal leukocytes in AMD retinae compared to normal 
retinae (see Chapter 3). With the benefits of increased accuracy and improved 
standardisation, quantitative immunohistochemistry based on confocal microscopy 
and digital image analysis also represents a useful teclmique with applications in 
measuring effectiveness of therapies (see Chapter 4). 
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CHAPTER3 
Leukocyte Common Antigen (CD45) Expression in 
Age-Related Macular Degeneration: 
Quantitative Analysis of Retinal Microglia and 
Choroidal-Leukocytes. 
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3.1 INTRODUCTION 
3.1.1 Leukocyte Common Antigen (CD45): Functions 
Leukocyte Common Antigen (CD45) is one of the most abundant leukocyte cell 
surface glycoproteins and is expressed exclusively upon cells of the hematopoietic 
system, excluding erythrocytes (Thomas 1989; Trowbridge and Thomas 1994). It is a 
cell surface receptor that belongs to the protein tyrosine phosphatase (PTP) class of 
enzymes. CD45 is now established as a critical component of the signal transduction 
machinery of both T and B lymphocytes (Irie-Sasaki et al. 2001). In particular, 
evidence from genetic experiments indicates that CD45 plays a pivotal role in 
antigen-stimulated proliferation of T lymphocytes and in thymic development 
(Trowbridge and Thomas 1994). CD45 is linked to the process of reversible protein 
tyrosine phosphorylation, a key regulatory mechanism for controlling the growth and 
division of eukaryotic cells. Different isoforms of CD45 are generated by alternative 
splicing and are expressed in cell type-specific patterns on functional subpopulations 
of lymphocytes (Beverley et al. 1992; Justement 1997). The CD45 isoforms 
comprise a major component of lymphocyteS and carry much of the carbohydrate of 
these cells. Some-"studies have estimated that 10% of the total lymphocyte surface is 
occupied by one or more of these isoforms, ·enabling CD45 to be employed as a 
useful leukocyte marker (Thomas 1989). CD45 immunolabelling thus provides a 
potential method to estimate the leukocyte content of normal and pathological tissue. 
A number of studies suggest the importance of CD45 in autoimmune regulation and 
promotion of disease processes in human and animal studies via signal transduction 
through antigen receptors. A point mutation in CD45, which appears to affect CD45 
dimerization, and a genetic polymorphism that affects alternative CD45 splicing may 
be implicated in multiple sclerosis in humans (Penninger et al. 2001; Jacobsen et al. 
2000). Patients who are deficient in CD45 present with Severe Combined 
Immunodeficiency (SCID) syndrome (Kung et al. 2000; Virts et al. 2003). In 
addition, studies in CD45 knock-out mice have demonstrated the importance of 
CD45 as a JAK tyrosine phosphatase that negatively regulates cytokine receptor 
activation involved in the differentiation,, proliferation and antiviral immunity of 
haematopoietic cells (Sasaki et al. 2001). 
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The role of CD45 in inflammatory processes and programmed cell death has also 
been investigated. CD45 has been observed to have a role in modulating signalling 
pathways in lipopolysaccharide-induced activation of cytokine production and 
arachidonic acid metabolism in macrophages (Pfau et al. 2000). Other studies have 
demonstrated that cross-linking of CD45 with monoclonal antibodies can induce cell 
death in T lymphocytes, and a significant role for the extracellular and/or 
transmembrane portion of CD45 in apoptosis signalling has also been suggested 
(Fortin et al. 2002). 
More recently, CD45 has been identified as an important potential drug target and 
central regulator involved in differentiation of autoimmunity, multiple hematopoietic 
cell lineages and antiviral immunity (Penninger et al. 2001). The applications of 
anti-CD45 immunotherapy for diseases such as systemic lupus erythematosus and 
radiolabelled CD45 antibodies to deplete malignant haematopoietic cells are 
currently being investigated (Dahlke et al. 2004). The involvement of CD45 in 
signalling pathways in inflammation and immune-mediated processes suggests it as a 
target for therap!es in diseases such as AMD, where immune-mediated events and 
inflammation are thought to play important roles (Tan et al., 2000a,b; Tan et al., 
2002; lrie-Sasaki et al. 2003). The modulation of these signalling pathways provides 
a rationale for the development of future anti-inflammatory therapies for AMD (see 
Chapter4). 
3.1.2 CD45 Expression in Normal Retina 
In human and animal neural tissue immunoreactivity to CD45 has been primarily 
described on microglia and vascular leukocytes. Significant staining of reactive 
microglia has been reported in rat brain (Akiyama et al. 1988), and other studies have 
reported readily detectable levels of CD45 in developing rat brain, with limited 
expression in adult brain (Perry and Gordon 1988; Perry and Lund 1989). 
In the human retina, Penfold et al. ( 1991) described subpopulations of microglia, 
immunolabelling for anti-CD45, anti-CD68 and anti-macrophage antigen. CD45 
immunoreactivity was localized on microglia in three main layers within the inner 
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retina in both vascular and avascular regions, although they were absent from the 
foveal pit. Labelling was evident on three main microglia types: parenchymal 
(ramified type) microglia, vessel-associated microglia located in the parenchyma 
(paravascular macrophages) and vessel-associated microglia in the perivascular 
space (perivascular macrophages). Further studies demonstrated paravascular, 
perivascular and parenchymal types located in three layers in inner retina - the 
NFUGCL, IPUINL border and INUOPL border, and paravascular microglia were 
shown by optical densitometry, to express higher levels of MHC antigens than 
neighbouring, non-vessel associated, parenchymal' microglia (Provis et al. 1995). 
CD45 is considered to be a superior marker of retinal microglia related to its 
specificity; CD45 does not label vascular elements unlike other markers such as 
MHC-II (Penfold et al. 1991). 
3.1.3 Microglial Activation and CD45 Expression 
Other Neural Pathology 
in 
Microglial cells are the resident immunocompetent cells of the retina and play an 
active role in neural inflammatory, immune and degenerative processes. Microglia 
contribute to host defence and repair and 'to the establishment and maintenance of 
neural damage (Minghetti and Levi 1998), and can synthesize and release substances 
crucial for the regulation of inflammation, immune responses and cell viability, 
including pro-inflammatory cytokines, neurotransmitters, nitric oxide, prostanoids 
and toxins (Gehrmann et al. 1995; Nakanishi 2003). In addition, perivascular and 
juxtavascular microglia play an important role as intrinsic antigen-presenting cells of 
neural tissue, initiating and maintaining CNS autoimmune injury due to their 
strategic localization close to the BBB, their rapid inducibility for MHC-1 and -II 
antigens and their potential scavenger role as phagocytic cells (fooyama et al. 1990; 
Gehrmann et al. 1995). 
Some authors have drawn parallels between AMD and other neurodegenerative 
diseases such as Alzheimer's disease (Anderson et al. 2002). Studies have 
demonstrated an important role for microglia in the pathogenesis of 
neurodegenerative and neuroinflammatory disorders including Alzheimer's disease. 
Using immunohistochemical teclmiques and quantitative image analysis, Carpenter 
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et al (1993) found a significant increase in activated microglia in the neocortex of 
Alzheimer's disease patients compared with controls and concluded that their role in 
the inflammatory response and possible secretion of neurotoxins could be important 
for neuronal degeneration in Alzheimer's disease. Similarly, microglial activation by 
amyloid beta~protein in senile plaques has recently been shown to contribute to 
neurodegeneration in Alzheimer's disease, possibly via protein kinase C substrates 
(Murphy et al. 2003). 
Recent studies have investigated a role for chronic inflammation and activated 
microglia in the pathogenesis of Alzheimer's disease (Luca et al. 2003; Versijpt et al. 
2003). A decrease in severity of symptoms and decreased progression of Alzheimer' s 
disease has been observed in patients taking,anti~inflammatory medications (McGeer 
and McGeer 1995;1999). This observation raised the possibility of using anti~ 
inflammatory therapeutic agents and/or immunotherapy in the treatment of 
Alzheimer's disease (McGeer and McGeer 1999; Dodel et al. 2003). A similar 
rationale may be used for the application of anti-inflammatory treatments in AMD 
(Penfold et al., 2001 ) . 
Quantitative studies of frontal cortex in patients with Alzheimer's disease showed 
increased CD45 immunoreactivity in situ and ex situ (Masliah et al. 1991; Penninger 
et al. 2001). These studies concluded that CD45 was a useful marker of microglial 
activity and postulated that CD45 may be necessary for regulation of cell function 
through modulation of intracellular signalling (Masliah et al. 1991; Penninger et al. 
2001 ). CD45 has also been used as an inflammatory marker in other disease models. 
In experimental autoimmune encephalomyelitis, subpopulations of macrophage 
lineage cells have been identified in adult CNS based on CD45 immunoreactivity, 
with differences observed in antigen-presenting ability and response to inflammatory 
stimuli assessed using flow cytometry (CD45high macrophages vs CD451ow microglia) 
(Dick et al. 1995; Ford et al. 1995). Microglia were found to be activated by 
infiltrating T cells in response to inflammation, increasing their number by up to. six 
times and increasing CD45 expression by up to four times (Ford et al. 1995). 
Another study using flow · cytometry utilized CD45 immunoreactivity to identify 
microglial and macrophage populations, and to monitor leukocyte response 
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following corticosteroid treatment of cerebral oedema of patients with brain gliomas 
(Badie et al. 2000). 
3.1.4 The Role of Choroidal Leukocytes in the 
Pathogenesis of AMD 
The role of subretinal choroidal leukocytes in AMD can also be investigated using 
CD45 as a leukocyte marker. The capacity of leukocytes to influence angiogenesis is 
is well established (Auerbach 1981 ). The pathogenic potential of choroidal 
leukocytes to stimulate vascular proliferation and exudation has _a!so been 
demonstrated in ultrastructural studies, where inflammatory cells (including 
multinucleated giant cells) have been obs~rved closely associated with subretinal 
new vessels and destruction of Bruch's membrane (Penfold et al. 1986,1987; 
Hutchinson et al. 1993). In addition, histopathological examination of excised 
neovascular membranes has revealed significant numbers of associated leukocytes 
and MPS cells within the fibrovascular complex (Lopez et al. 1991 ). A significant 
nwnber of immunocompetent HLA-DR and HLA-DQ-expressing cells including 
glia, pigment epithelial and vascular endothelial cells have also been observed in 
excised subretinal membranes (Baudouin et ·al. 1992). Monoclonal antibodies to 
other immunocompetent leukocytes -including B cells and NK lymphocytes, 
suppressor-cytotoxic T cells and monocytes were also detected. Other studies have 
revealed evidence of a cell-mediated chronic inflammatory response within excised 
surgical neovascular fronds including endothelium-lined vascular channels, 
macrophages, myofibroblasts, fibrocytes, glial cells, erythrocytes, and lymphocytes 
(Kim et al. 1996). Extraceliular interstitial constituents included collagen fibrils, 
basal laminar deposits, fibrin and young elastic fibrils. 
A structurally and functionally normal choroidal vasculature is essential for normal 
function of the retina, and compromised choroidal blood flow may result in 
photoreceptor dysfunction and death (reviewed Penfold et al. 2001). Recent studies 
examining the effects of aging on the choroidal vasculature suggest that 
choriocapillaris flow may be reduced in aging and AMD, and that this loss of 
choriocapillaris can be associated with the Bruch's membrane deposits that are 
hallmarks of AMD (Grunwald et al. 1998a,b; Ciulla et al. 2001). Furthermore, 
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studies have shown that RPE cells may stimulate the fonnation and regression of 
choroidal neovascularisation and that RPE loss can result in loss of the 
choriocapillaris (Lutty et al. 1999; reviewed Schlingemann 2004). 
Studies have investigated the role of choroidal leukocytes and an inflammatory 
choroidopathy in the pathogenesis of other ocular diseases, including diabetic 
retinopathy, where choriocapillaris dropout, basement membrane thickening and 
even choroidal neovascularisation have been observed (Lutty et al. 1997). Increased 
numbers of polymorphonuclear leukocytes (PMNLs) have been observed in the 
human diabetic choroidal vasculature compared with that in non-diabetics, and 
leukocytes were often associated with choriocapillaris degeneration and plugged or 
queued in atrophic capillary segments (Lutty et al. 1997). Similarly, elevated levels 
of P-selectin and ICAM-1 have been observoo in diabetic choroids (McLeod et al. 
1995). These substances stimulate leukocyte (P:MNL) rolling and adhesion to 
endothelial cells. Choroidal neovascularisation has also been reported in patients 
with diabetic retinopathy, associated with. choriocapillaris dropout; choroidal 
neovascularisation in diabetics was also often not detected clinically because of a 
high rate of autoinfarction (Cao et al. 1998): The presence of increased numbers of 
choroidal leitkocytes with the potential to.release a host of angiogenic factors and 
proteolytic enzymes may promote the formation of choroidal new vessels and 
contribute to destruction of Bruch's membrane (see also Chapter 1). 
3.1.5 CD45 Expression and,AMD 
There is considerable evidence that AMD involves both inflammatory and 
immunological mechanisms (see Chapter 1; reviewed Penfold et al. 2001). 
Consistent with this, microglia have been demonstrated to upmodulate expression of 
MHC·II and become activated in incipient and endstage AMD (Penfold et al. 1997). 
In animal models of retinal degeneration activated microglia have been implicated in 
the induction of photoreceptor death, and microglial cells can release soluble 
products that induce degeneration of cultured photoreceptor cells via apoptosis 
(Roque et al. 1999). Recently, a study has shown that activation of microglia may be 
involved directly in photoreceptor death in AMD, retinitis pigmentosa and late-onset 
outer retinal degeneration (Gupta et al. 2003). Numerous enlarged, amoeboid 
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activated microglia containing rhodopsin-positive cytoplasmic inclusions were found 
to be present in the outer nuclear layer in regions of ongoing photoreceptor cell death 
(Gupta et al. 2003). Choroidal leukocytes including macrophages, lymphocytes, mast 
cells and giant cells have been shown in histopathological and ultrastructural studies 
of AMD (Penfold et al. 1986; Lopez et al. 1991; Pavan and Margo 1996); these cells 
have the potential to release a host of angiogenic factors and proteolytic enzymes 
which promote the formation of choroidal neovascularisation and lead to the 
destruction of Bruch's membrane (Penfold et al., 2001; Das and McGuire, 2003; 
Schlingemann 2004 ). 
The rationale for examining the expression of CD45 in AMD includes its exclusivity 
as a leukocyte marker, its effectiveness as a specific immunological marker for 
microglia and microglial activation and its pivotal role in immune regulation in a 
number of pathological processes via signal transduction through antigen receptors 
(see Chapter 3.1.1). This study aims to quantify the expression of CD45 on retinal 
microglia and choroidal leukocytes in AMD retinae compared with age-matched 
normal and young adult retinas, using quantitative immunohistochemical techniques. 
It also aims to determine if there are differences in CD45 expression in the different 
subgroups o(AMD, including incipient and late stage disease. The exclusivity and 
specificity of CD45 to leukocyte lineage cells, including microglia, together with 
image analysis technology provides a practical and theoretical basis for the 
measurement of the inflammatory cell content of retinal tissue. 
3.2METHODS 
3.2.1 Specimens 
Donor human eyes ranging from ages 5 - 94 (n=45) were obtained, subsequent to 
informed consent through the Lions New South Wales Eye Bank, and with approval 
of the Human Ethics Committee (University of Sydney), according to the tenets of 
the Declaration of Helsinki. Eyes with a known history of specific ocular disease 
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other than AMD or chronic neurological disease were excluded from the study. 
Following removal of the anterior segment and vitreous, specimens were fixed in 2% 
paraformaldehyde/ O.lM phosphate-buffered saline (PBS; pH 7.4) and stored at 4°C. 
Average post-mortem delay from time of death to fixation for all specimens was 
12.3hrs +/- 4.0 hrs (Appendix 1). 
3.2.2 Tissue Preparation 
Using 7mm and 4mm trephines, discs of tissue comprising all ocular layers from 
neural retina to sclera were cut from corresponding macular and paramacular 
locations. The neural retina was dissected away from the RPE and choroid and was 
prepared for immunohistochemistry as flatmounts. Adjacent 4mm full thickness 
discs of all ocular layers were frozen in Tissue Tek™ medium OCT (Sakura, Japan) 
using liquid nitrogen-cooled isopentane and cut as 20 J.l.ITI thick frozen sections. The 
RPE and choroid from macular trephines were postfixed in 2.5% glutaraldehyde and 
2% osmium tetroxide, bloc stained in uranyl acetate, dehydrated through graded 
alcohols and acetone and embedded in Epon-araldite resin (ProSciTech, Australia) 
and cured at 60°C. ,Semi thin sections were cut using a Reichert Ultramicrotome, 
/ 
stained with toluidine blue and examined by light microscopy. 
3.2.3 Classification 
Toluidine blue-stained semithin sections were graded for the presence or absence of 
drusen, basal laminar deposit, RPE abnormalities, disciform scars with choroidal 
neovascularisation, or GA. On the basis of this survey, corresponding samples of 
neural retina were classified into three major groups including young normal eyes 
(less than 40 years), aged normal eyes (over 75 years) and AMD eyes (Table 3.1). 
AMD specimens were also classified into five subgroups: disciform scar, GA, 
drusen, basal laminar deposit and pigmentary disturbance specimens (Table 3.2). 
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Table 3.1a Mean Age of Patients 
100 
90 
80 
70 
60 B • Young Norrrsl < 40yrs f 50 c Aged Norrrsl > 75 yrs CG ~ C A W 40 
30 
20 
10 
0 
GROUP No. Mean Age (yrs) 
Young Normal < 40yrs 12 22.8 +/- 10.3 
Aged Normal > 75 yrs 11 77.0 +/- 4.4 
AMD 22 80.6 +/- 6.9 
Table 3.1a Specimen groups from the histopathological survey showing number of 
specimens and mean ages. The mean age of Aged Normal and AMD specimens is not 
significantly different (p>0.05, Student's t test). 
Table 3.1b Delay Time to Fixation 
30 
25 
20 
I I I 
f 
• Young Norrrsl < 40yrs 
;:::, 15 ~ Aged Normal > 75 yrs 0 
% AMD 
10 
5 
0 
GROUP No. Delay to Fixation (hrs) 
Young Normal < 40yrs 12 19.7 +/- 5.4 
Aged Normal > 75 yrs 11 16.8 +/- 3.6 
AMD 22 11 .6 +/- 4.3 
Table 3.l b Young Normal, Aged Normal and AMD specimens from the 
histopathological survey, showing delay to fixation of specimens. The mean delay to 
fixation (hrs) of Young Normal, Aged Normal and AMD specimens is not significantly 
different (p>0.05, ANOVA). 
Table 3.2a Mean Age of Patients in AMD 
Subgroups 
100 
901 r I I• Disciform Scar 
80 
70~ -...___J J• Geographic 
60 t--
~I Atrophy 
e o Drusen 
ftS 50 Cl) 
> 40 
30 t 
~ 
1
• Basal Laminar 
20 
Deposit 
1 0~ 
• Pigmentary 
~ I Disturbance 
0 
SUBGROUP No. Mean Age (yrs) 
Disciform Scar (DS) 5 79.3 +/- 2.3 
Geographic Atrophy (GA) 3 88.3 +/- 4.1 
Drusen (DR) 8 84.3 +/- 1.1 
Basal Laminar Deposit (BLD) 3 77.3 +/- 1.5 
Pigmentary Disturbance (PD) 3 74.0 +/- 4.5 
I 
Table 3.2a Subgroups of AMD specimens from the histopathological survey 
showing the number of specimens and mean ages. Comparison of mean ages between 
subgroups reveals significant differences in the following groups: DS vs GA, GA vs 
BLD, GA vs PD, DR vs PD (p<0.05, ANOV A). 
Table 3.2b Mean Delay Time to Fixation of l Specimens 
18 
16 I I I. Disciform Scar 
14 
• Geographic 
12 Atrophy 
e 10 o Drusen ;:, 
0 8 :I: 
6 ~-- I ~ I• Basal Laminar 
4 + I 
Deposit 
2 1--
~
1
• Pigmentary 
Disturbance 
0 
SUBGROUP No. Delay to Fixa tion (hrs) I 
I 
Disciform Scar 5 14.3 +/- 1.2 
J 
Geographic Atrophy 3 11.0 +/- 2.0 
Drusen 8 9.6 +/- 4.9 
Basal Laminar Deposit 3 6.6 +/- 2.3 
Pigmentary Disturbance 3 12.0 +/- 3.8 
Table 3.2b Subgroups of AMD specimens from the histopathological survey 
showing mean delay to fixation. The mean delay to fixation (hrs) is not significantly 
different between the subgroups (p>0.05, ANOV A). 
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3.2.4 Immunohistochemistry 
3.2.4.1 Indirect Immunofluorescence Labelling 
3.2.4.1.1 Retinal Flatmounts 
Flatmount specimens were single-labelled with a 3-step indirect immunofluorescent 
technique. After removal of adherent vitreous, retinal trephines were rinsed in several 
changes of 0.1M Tris-Buffered Saline (TBS) pH 7.6 then left in TBS overnight at 
4°C. Antigen retrieval was performed by heating specimens in 0.01M citrate Buffer 
pH 6.0/ 0.4% saponin at 85-90°C for 20 mins. Following several rinses with TBS, 
specimens were blocked for 5 days at 4°C in 10% normal sheep serum/ 0.4% 
saponin/ TBS to permeabilize tissue and to reduce non-specific binding of antibody. 
An further incubations were done at 4°C on a shaker table. Retinae were incubated 
for 5 days in primary antibody - mouse anti-human CD45 (Leukocyte Common· 
Antigen, anti-HLE-1, 1:50 dilution, Becton Dickinson, Australia)- in 0.4% saponin/ 
TBS. Retinae were then rinsed in TBS before incubating in secondary antibody 
(biotinylated sheep anti-mouse IgG, 1:50, Amersham Pharmacia Biotech Australia) 
for 48 hrs. Finally, specimens were pla~ed in fluorochrome (streptavidin-conjugated 
Cy3, 1:100 Zymed Laboratories, San Francisco, USA) for 3 hours before being 
mounted in glycerol on gelatin-coated slides, and coverslipped (see Figure 2.1). 
3.2.4.1.2 Frozen Sections 
Frozen sections were immunolabelled u,sing CD45 in the following manner. Slides 
were rinsed in O.IM PBS (pH 7.4) for 5 mins then preincubated in 10% normal 
sheep/ PBS for 15 mins to reduce bac}<ground labelling. Specimens were then 
incubated in CD45 antibody (1 :50 dilution/ 2% ,normal sheep serum/ PBS) overnight 
on a shaker table at 4°C. Following rinsing in PBS, sections were incubated in 
secondary antibody in biotinylated sheep anti-mouse IgG (Amersham Pharmacia 
Biotech, 1:50 dilution/ 2% normal sheep serum) for 2 hours. Frozen sections. were 
then incubated in streptavidin-conjugated Cy3 (1:100 dilution/ PBS, Zymed 
Laboratories) for 1 hour to visualise the CD45 immunolabelling. Specimens were 
mounted in a glycerol-based anti-fade agent 1,4-diazabicyclo[2.2.2]octane (DABCO, 
Sigma, Australia) and coverslipped for viewing. 
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Some frozen sections (n=6) of both AMD and normal eyes were double 
immunolabelled using CD45 and GF AP (glial fibrillary acidic protein, an 
intermediate filament marker used to identify retinal macroglia) to visualize the 
morphological relationship of CD45-labelled microglia and GF AP-labelled 
macroglia (astrocytes and Muller cells). Briefly, following 15 mins preincubation in 
10% normal sheep/ 10% normal goat serum/ PBS, specimens were incubated in a 
primary antibody mixture of mouse anti-human CD45 (1 :50 dilution/ 2% normal 
sheep serum/ PBS) and rabbit anti-cow GFAP (DAKO Australia, 1:1000 dilution/ 
2% normal goat serum/ PBS) overnight on a shaker table at 4°C. Sections were 
incubated in a mixture of secondary antibody of biotinylated sheep anti-mouse IgG 
(Amersham, 1:50 dilution/ 2% normal sheep serum) and Cy5-conjugated anti-rabbit 
lgG (Zymed Laboratories, 1:50 dilution/ 2% normal goat serum) was used to 
incubate sections for 2 hours, followed by incubation in streptavidin-conjugated Cy3 
(1 :100 dilution/ PBS, Zymed Laboratories) for I hour to visualise the CD45 
immunolabelling. 
3.2.4.2 Indirect Immunoperoxidase Labelling 
Multiple frozeiJ. .sections (n= l2, 2 specimens from each AMD subgroup and controls) 
were also examined using peroxidase ipununohistochemistry to allow correlation by 
manual counting of labelled cells. Briefly! specimens were labelled in a similar 
fashion to the indirect immunofluorescent t,echnique described above, however 
antibody binding was visualized using ExtrAvidin-Peroxidase (1 :200 dilution, 
Sigma, Australia) and Sigmafast 3,3 '-Diaminobenzidine tablet sets. Specimens were 
then dehydrated through graded alcohols, cleared in xylene then mounted and 
coverslipped in DePeX (BDH Pty Ltd, Australia) for examination under standard 
light microscopy. CD45 immunolabelled cells were manually counted in a masked 
fashion using an Olympus microscope with X40 objective and 0.2mm graticule. 
· 3.2.5 Confocal Microscopy 
:- Retinal flatmounts were examined with a Leica TCS-NT scanning laser confocal 
i 
microscope system (Leica Microsystems Heidelberg GmbH, Germany) (see Figure 
49 
Chapter 3: Leukocyte Common Antigen (CD45) Expression in AMD 
2.2). Fluorochrome-labelled specimens were stimulated by argon-krypton laser at 
568nm and optical sections were collected by photomultipliers using a PL APO 16x 
oil-immersion objective and appropriate band-pass filters. Standardized settings 
including the photomultiplier gain, offset, aperture size and laser power were 
maintained rigorously to allow comparison of cell fluorescence intensity between 
different specimens. A standardized 3-dimensional optical grid with dimensions of 
625 X 625 X 61.5 J..U11 (42 sections, each 1.5 Jltl1 thick) was placed over each 
specimen and five fields were chosen at random per flatmount with the optical series 
stored digitally for later image analysis (Figure 3.la,b). Internal controls from similar 
areas of the same retina as well as autofluorescent RPE and a synthetic polymer were 
used as fluorescence standards to calibrate f}.uorescence intensity across different 
runs and different confocal microscopy sessions. Dilution experiments were also 
conducted to establish the relationship between increasing concentration of antibody 
and increasing fluorescence intensity, and the optimal antibody concentration to use 
for experiments (see Appendix II). 
3.2.6 Digital IJllage Analysis 
/ 
Antibody expJ:eS'sion was quantified using digital image analysis of sampled 
immunofluorescence-labelled confocal microscope images. Optical sections were 
imported into NIH Image, a public dpmain image analysis program developed for 
Macintosh computer (National Institute of Health, USA). Images were converted to a 
greyscale (Figure 3.lc), with labelled elements segmented from background via a 
standardised histogram-based thresholding technique, based on the maximum 
perpendicular bisector method· (Wong 1995~ (Figures 3.1d-f). Briefly, automated 
plots ofvoxel (volume pixel) vs greyscale levels of the images were obtained and the 
maximum perpendicular bisector of the line joining the peak to trough values used to 
fmd the thresholding level. Images were then su~jected to particle analysis (Figure 
3.1g). Programs were written in the NIH Image Macro Programming language to 
facilitate automation of the image analysis technique (Figure 3.1 i). From region of 
interest (ROI) measurement data (area and mean greyscale value), other parameters 
were calculated using Microsoft Excel (Figure 3.1h). These recorded parameters 
included percentage area of field labelled, total fluorescence intensity per field (total 
particle area x average greyscale value) and average fluorescence intensity per unit 
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Z.series of 
Confocal 
Optical Sections 
lmmunolabeled 
microglia 
Figure 3.1a Confocal principle showing optical sectioning of three-
dimensional object and Z-series stack of individual sections. 
Figure 3.lb Confocal optical slice ofCD45 positive Cy3 fluoroscent-
labelled microglia. 
Figure 3.1c Conversion of coloured confocal optical slice (Figure 3.lb) 
to an 8- bit greyscale image, utilising the Nlli Image LUT (Look Up Table: 
Greyscale) function. The range of colour is converted to a monochrome 
image with a range of 256 (28) greyscales in an 8-bit system from absolute 
black (255) to absolute white (0). 
v 
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VOXEL GREYSCALE 
(0-255 Greylevels) 
b 
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Figure 3.ld Technique for segmentation of regions of interest (ROI) by 
thresholding. The histogram demonstrates a typical plot of voxel (volume 
pixel) greyscale versus voxel count of a confocal optical section. The 
thresholding level is established by the maximum perpendicular bisector 
technique (see text): a line (red line) joins the peak count (a) to lowest 
appropriate count (b); the maximum length of the perpendicular cd (green 
line) to line ab towards slope of curve is found (double arrow); from (d) a 
line (dotted blue line) perpendicular to the greyscale axis arrives at (e), which 
is used as appropriate thresholding greylevel. 
Figure 3.1e Segmentation of immunolabelled structures from 
background via the thresholding technique described in Figure 3.1d. 
Segmented regions of interest (ROis) are highlighted in red against the 
greyscale background. 
Voxel 
GreyscaJe 
Value 
Figure 3.1f Surface profile plot of voxel greyscale measurements of an 
irnmunolabelled confocal optical section. Higher intensity areas are 
represented by taller peaks coloured green-red over the background blue-
pink, showing the in situ relative distribution of immunolabelled antigen in a 
retinal tlatmount. 
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Figure 3.1g Particle analysis of the segmented area using the Nlli Image 
Particle Analysis Function, demonstrating counting and labelling of regions 
of interest (ROis). 
AREA MEAN TOTAL INTENSITY 
110 90.52 9957.2 
21547 98.98 2132722.06 
19047 98.6 1878034.2 
593 90.76 53820.68 
65 86.35 5612.75 
132 89.29 11786.28 
124 89.18 11058.32 
287 89.34 25640.58 
58 87.6 5080.8 
50 86.34 4317 
108 90.51 9594.06 
80 86 6880 
86 87.5 7525 
87 87.55 7616.85 
59 87.05 5135.95 
66 91.65 6048.9 
58 88.72 5145.76 
534 92.07 49165.38 
SUM AREA SUM TOTAL INTENSITY 
43308 4254809.12 
Figure 3.1h Exported output data measurements showing the area, 
intensity (greyscale value) and mean intensity for each ROI and total area and 
sum total' intensity measurements. 
macro 't24ecrb50twenthou'; 
var 
name : string; 
begin 
name:=getstring('Name of file'); 
setpalette('grayscale'); 
subtractbackground('2drollingball',50); 
enhancecontrast; 
setthreshold(24); 
setparticlesize(10,20000); 
analyzeparticles('label,reset'); 
showresults; 
set export('measurements'); 
export('c:\My Documents\Research\DATA\convresult\'name't24'); 
end 
Figure 3.1i Sample Macro program developed and written for Nlli Image to 
automate image analysis technique with thresholding and filter parameters. 
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area. Calculations and graphing of results were performed in the Microsoft Excel 
spreadsheet program, with data exported for statistical analysis. 
3.2. 7 Statistical Analysis 
Measurements from AMD and control group specimens including total fluorescence 
intensity and percentage area of immunoreactivity were assessed statistically by 
unpaired Studenf s T tests for comparison of means of two groups, and ANOV A for 
comparison of means of three or more groups, utilising the Instat statistical program 
for Macintosh computer (GraphPad Software Systems). 
3.3 RESULTS 
3.3.1 Morphological Results 
3.3.1.1 Normal Retinae 
In retinal flatmount specimens, CD45-labelled retinal microglia had a laminar 
topography with distributions in the NFL, IPL and INU OPL border, and differing 
morphological fol'Iils apparent in each of the three main layers (Figure 3.2). Nerve 
fibre layer microglia were of the parenchymal type and appeared elongated with thin 
cell nrocesses following the direction of the nerve fibre bundles (Figure 3.3). 
Perivascular microglia were associated with larger vessels in the NFL, had a more 
rounded morphology and fewer cell processes (Figure 3.4). In the IPL, microglia 
demonstrated a more dendritic morphology with multiple smooth processes 
extending from a smaller oval cell body (Figure 3.5). 
3.3.1.2 AMD retinae 
CD45-expressing microglia had a laminated topographic distribution throughout all 
AMD retinae studied (Figure 3.7). In the NFL, CD45-labelled microglia had an 
elongated morphology aligned with the long axis of the nerve bundles in AMD 
retinae similar to control retinae (Figure 3.6). In AMD retinae, perivascular 
macrophages in the NFL were also present around the larger vessels. CD45-positive 
cells in the IPL appeared to be mainly microglia of dendritic morphology. 
Hypertrophy of these forms of microglia was observed especially in the IPL layer in 
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Figure 3.2 Immunoperoxidase-labelled CD45-positive microglia (MG) in 
normal retina demonstrating a laminar topography with distribution in NFL, IPL and 
at the INL/ OPL border and around a retinal blood vessel (BV). 
Figure 3.3 Inverted fluorescent image of CD45-labelled parenchymal 
type microglia in normal retina, showing narrower cell processes (arrows) 
correlating to the direction of nerve fibre layer (NFL) bundles (Bar = 50JJ.m). 
Figure 3.4 Inverted fluorescent image of CD45-labelled ramified type 
microglia in normal retina associated with retinal blood vessel, with fewer 
cellular processes (Bar = 50J..Ull). 
Figure 3.5 Inverted fluorescent image of CD45-labelled microglia of 
dendritic type in normal retina showing branching cellular processes and 
rounded cell bodies (Bar = 50J..llll). 
Figure 3.6 CD45-Iabelled parenchymal microglia with elongated cell 
processes aligned with the long axis of the nerve bundles (arrowheads) in the 
NFL in an AMD specimen (disciform scar) (Bar = l001J.m). 
Figure 3. 7 Immunofluorescent CD45-Iabelled retinal microglia (MG) in AMD 
specimen (disciform scar) showing laminar distribution in NFL, IPL and at the INL/ 
OPL border and perivascular macrophage around retinal blood vessel (BV). 
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AMD retinae. Hypertrophied microglia had enlarged cell bodies, cell body vacuoles 
and multiple extending cell processes (Figure 3.8). Thickening and vacuolation of the 
processes was also observed. In general, perivascular microglia had a more globular 
and less ramified appearance. The increased hypertrophy and more globular 
morphology of microglia appeared more evident in late exudative AMD (disciform 
scar) specimens compared to incipient AMD (drusen, pigmentary disturbance) and 
GA specimens (Figures 3.9a-g). 
Frozen sections double-labelled with CD45 and GFAP demonstrated CD45-positive 
parenchymal microglia associated with GFAP-labelled astrocytes and Muller cell end 
feet predominately in the NFL. AMD specimens appeared to have more intense 
GF AP labelling than normal specimens, in addition to the more hypertrophic 
microglia (Figures 3.10a,b; cultured retinal microglia Figure 3.10c). Occasionally, 
Muller cell processes extendiilg between the ILM and OLM were noted to display 
low intensity GF AP immunolabelling. 
3.3.2 Quantitative Image Analysis 
/ 
3.3.2.1 CD45-Iabelled retinal microglia in flatmount 
specimens 
Mean CD45 expression on retinal microglicr measured by total fluorescence intensity 
was significantly higher in aged normal retinae (43.3 fu +/- 3.3) compared to young 
normal retinae (25.6 fu +/- 4.8) (p<O.OOl). Ov~rall, mean CD45 expression was also 
15% higher in AMD retinae (49.7 fu +/- 4.5) than aged normal retinae (43.3 fu +/-
3.3, p<O.Ol, Table 3.3). There was a differential expression ofCD45 in subgroups of 
AMD retinae. A significantly higher expression of CD45 was found in retinae with 
pigmentary disturbance (56.0 fu +/- 4.4) and disciform scar (62.2 fu +/- 5.6) lesions 
than in other AMD subgroups (44% and 29% increased expression relative to aged 
normal subgroup respectively). There was non-significant but lower expression of 
CD45 in the GA subgroup (35.4 fu +/- 5.5) than in age-matched controls (43.3 fu +/-
3.3, p>O.OS, Table 3.3). Comparison of CD45 expression in retinal microglia in 
incipient AMD lesions (pigmentary disturbance, drusen and BLD) vs late AMD 
lesions (disciform scar and GA) demonstrated a 13% increase in levels in incipient 
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Figure 3.8a Inverted fluorescent image of CD45-labe1Jed microglia in 
AMD (geographic atrophy) specimen showing enlarged cell bodies (white 
arrowhead) and cellular processes with terminal varicosities (black arrow) 
(Bar = 50J.!m). 
Figure 3.8b Magnified confocal fluorescent image ofCD45-labelled 
parenchymal microglia in normal retinae (A) and AMD retinae (disciform scar) (B) 
demonstrating hypertrophy of cell body and thickening of processes. 
Figure 3.9a Inverted fluorescent image of CD45-labelled microglia in 
young normal specimen (Bar= 1 OOJ.1111). 
Figure 3.9b Inverted fluorescent image of CD45-Iabelled microglia in 
aged normal specimen (Bar = 1 OOflm). 
Figure 3.9c Inverted fluorescent image of CD45-Iabelled 
microglia in disciform scar AMD specimen (Bar = 1 OOJ.tm). 
Figure 3.9d Inverted fluorescent image ofCD45-labelled 
microglia in geographic atrophy AMD specimen (Bar= 1 OOJ.tm). 
Figure 3.9e Inverted fluorescent image ofCD45-labelled 
microglia in drusen AMD specimen (Bar = lOOJ.Ull). 
Figure 3.9flnverted fluorescent image ofCD45-labelled 
microglia in basal laminar deposit AMD specimen (Bar = 1 OOJ..Lm). 
Figure 3.9g Fluorescent image ofCD45-labelled microglia in 
retinal pigment abnormality AMD specimen (Bar = 1 OOJ..UD.). 
Table 3.3 Quantitative analysis of CD45 expression on retinal 
microglia 
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Change p value 
Total Fluorescence relative to 
Intensity Aged Normal 
Group (fluorescence units) eyes 
Young Normal 25.6 +/- 4.8 
Aged Normal 43.3 +/- 3.3 
AMD 49.7 +/- 4.5 +15% p<O.Ol 
Disciform Scar 62.2 +/- 5.6 +44% p<O.OOI 
Geographic Atrophy 35.4 +/- 5.5 -18% NS 
Drusen 46.6 +/- 4.6 +8% NS 
Basal Laminar Deposit 48.3 +/- 4.1 +12% NS 
Pigmentary Disturbance 56.0 +/- 4.4 +29% P<0.01 
Table 3.3 Quantitative analysis of total fluorescence intensity of CD45-positive microglia 
in retinal flatmounts. Overall, a 15% increase in CD45 expression is seen in AMD specimens 
compared with Aged Normals (p<0.01). The disciform scar subgroup (44% increase, p<0.001) 
and the pigmentary disturbance subgroup (29% increase, p<0.01) show a significant increase 
in CD45 expression compared to Aged Normals. 
Figure 3.10a Aged normal specimen double-labelled with CD45 (red) 
and GFAP (glial fibrillary acidic protein) (blue) demonstrating the 
relationship of macroglia (astrocytes, AC) and microglia (MG) forming the 
glia limitans component of the blood-retinal barrier around a retinal blood 
vessel (BV). 
Figure 3.10b AMD specimen (disciform scar) double-labelled with 
CD45 (red) and GFAP (blue), demonstrating more intense GFAP labelling in 
astrocytes (AC) surrounding a retinal blood vessel (BV), with associated 
perivascular type microglia (MG). 
Figure 3.10c Mixed human retinal glial cell culture labelled with CD45 
(red) and GFAP (blue) demonstrating different in vitro morphology of 
microglia (MG), astrocytes (AC) and Muller cells (Mu) (Cell culture courtesy 
ofMs L. Wen). 
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lesions (49.0 fu +/- 4.5) compared to aged controls (43.3 +/- 3.3), but most with late 
AMD lesions (52.2 +/- 5.6) (21% increase in expression relative to aged normal 
specimens, p<O.Ol, Table 3.4). 
3.3.2.2 CD45-labelled choroidal leukocytes 
Measurement of CD45 immunoreactivity by .quantitative image analysis on choroidal 
leukocytes demonstrated similar levels of CD45 expression in aged-matched normals 
(26.1 fu +/- 0.9) and choroids of AMD eyes (26.3 fu +/- 0.9) (p>O.OS), but increased 
CD45 expression in these groups relative to young normals (24.0 fu +/- 0.6, p<O.OOl, 
Table 3.5). Differential CD45 expression was also found within the AMD subgroups. 
Increased CD45 immunoreactivity was highe&t in choroids from the pigmentary 
disturbance group (28.0 fu +/- 0.6) and disciform scar lesions (27.8 fu +/- 0.7) 
compared with age-mats;hed control~ (p~O.O 1 ). and generally lower, but not 
significantly in choroids from GA (25.8 fu +/~ 0.4), drusen (25.4 fu +/- 0.6) and BLD 
specimens (25.8 fu +/- 0.6, p>0.05, Tabl((, 3.5). Comparison of CD45 expression on 
choroidal leukocytes in incipient AMD lesions (pigmentary disturbance, drusen and 
BLD) and late AMD lesions (disciform scar and GA) demonstrated increased CD45 
expression levels in choroids from late AMD lesions (27.1 fu +/- 0.6) compared to 
choroids from incipient lesions (26.0 fu +/- 0.6) (p<0.05), which were similar to age-
matched controls (26.1 fu +/- 0.9, p>O.OS, Table 3.6). 
3.3.3 Manual counts of CD45-labelled choroidal 
leukocytes 
Masked manual counts of CD4;5;-labelled choroidal leukocytes (Figure 3.11) 
demonstrated increased numbers (17%) of irrpnunolabelled cells in AMD choroids 
(35.4 cells/ mm2 +/- 2.4) compared to age4-matched normal specimens (30.2 cells/ 
mm2 +/- 2.4, p<0.001) and young normal specimens (20.2 cells/ mm2 +/- 2.3, Table 
3.7). Analysis of choroids from AMD specimens by subgroup showed a significant 
differential expression, with pigmentary disturbance lesions having the highest 
number of CD45-positive cells (73.7 cells/ mm2 +/- 2.3, a 144% increase relative to 
aged normals, p<0.001) followed by disciform scar lesions (54.0 cells/ mm2 +/- 2.4, 
a 79% increase relative to aged normals, p<0.001). A similar trend of lower manual 
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Table 3.4 CD45 Expression on Retinal Microglia in 
Incipient vs late AMD Subgroups 
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Total Fluorescence Intensity 
Group (fluorescence units) 
Young Normal 25.6 +/- 4.8 
Aged Normal 43.3 +/- 3.3 
Incipient AMD (DRBLD,PD) 49.0 +/- 4.5 
Late AMD (DS,GA) 52.2 +/- 5.6 
Table 3.4 Quantitative comparison of CD45 expression in retinal microglia in 
incipient AMD (drusen, basal laminar deposit, pigmentary disturbance) subgroups vs 
late AMD (disciform scar, geographic atrophy) subgroups. A significant increase in 
CD45 expression is seen in incipient AMD specimens (13%, p<0.05) and late AMD 
specimens (21% p<O.OOl) compared to Aged Normal specimens. 
Table 3.6 Quantitative analysis of CD45 expression on 
choroidal leukocytes in frozen sections 
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Young Normal 
Aged Normal 
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Total Fluorescence Intensity 
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26.3 +/- 0.9 
27.8 +/- 0.7 
25.8 +/- 0.4 
25.4 +/- 0.6 
25.8 +/- 0.6 
28.0 +/- 0.7 
Table 3.5 Quantitative analysis of immunofluorescence CD45-labeled expression on 
choroidal leukocytes in AMD subgroups vs Aged Normals and Young Normals. Similar levels 
ofCD45 expression are seen overall in AMD and Aged Normal groups (p>0.05), however the 
disciform scar and pigmentary disturbance subgroups show a significant increase in 
comparison to Aged Normals (p<O.Ol). 
Table 3.6 CD45 Expression on Choro idal Leukocytes in 
Incipient vs Late AMD Subgroups 
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Total Fluorescence Intensity 
Group (fluorescence units) 
Young Normal 24.0 +/- 0.6 
Aged Normal 26.1 +/- 0.9 
Incipient AMD (DR,BLD,PD) 26.0 +/- 0.6 
Late AMD (DS,GA) 27.1 +/- 0.6 
Table 3.6 Quantitative analysis of immunofluorescence CD45-Iabelled choroidal 
leukocytes in incipient AMD lesions (drusen, basal laminar deposits and pigmentary 
disturbance), late AMD lesions (disciform scar and geographic atrophy) and controls. 
In particular, a significant increase in CD45 expression is seen on late AMD specimens 
compared to incipient AMD specimens {p<0.05), which were similar to Aged Normal 
specimens (p>0.05). 
Figure 3.11a Immunoperoxidase-labelled CD45-positive choroidal leukocytes 
(CL) below retinal pigment epithelium (RPE), showing nearby red blood cells (RBC) 
with mild endogenous peroxidase expression located within choroidal vessels in a 
aged normal retina. 
Figure 3.11 b lrnmunoperoxidase-labelled CD45-positive retinal microglia 
(arrows) and groups of choroidal leukocytes (arrowheads) below retinal pigment 
epithelium (RPE) in an AMD (drusen) retina. 
'.. o-
Chapter 3: Leukocy te Common Antigen (CD45) Expression in AMD 
counts of choroidal leukocytes for GA, BLD and drusen specimens was also noted, 
with reductions of 36%, 57% and 43% of CD45-positive cells relative to aged 
normal specimens respectively (p<O.OOl). Overall the manual counts of CD45-
positive cells correlated to the quantitative image analysis, including the trend of 
differential CD45 expression in choroids from AMD subgroups; however there was 
some minor variation in the rankihg of AMD choroid subgroups (Table 3.7). 
3.4 DISCUSSION 
Whilst the exact etiology of AMD remains unknown, immunological responses in 
neural retinal microglia and vascular elements appear to be related to early 
pathogenetic changes in AMD (Penfold et al. 1997). Both increased MHC-II antigen 
expression and astrocytic degeneration associated with the glia limitans have been 
shown to be evident in AMD-affected and aging retinae (Madigan et al. 1994; 
Penfold et al. 1997). 
In exudative AMD, subretinal choroidal neova~cularisation disrupts the outer BRB 
resulting in exudation into the subretinal space and subsequent loss of photoreceptor 
function. The signals which provoke new v:essel growth include growth factors (e.g. 
VEGF) and other proinflammatory cytokines, although the exact mechanisms remain 
to be elucidated (Schlingemann 2Q04). Previous histopathological studies have been 
mainly concerned with the changes occurring in the outer retina (Sarks 1976; Penfold 
et al. 1985; Bressler et al. 1988; Gehrs et al. 1992) Subsequently, the functional 
failure of the RPE has been suggested as a·primary cause of the pathological changes 
seen in AMD (Bressler et al. 1988; Bressler et al. 1990). However, other studies 
suggest that degenerative changes may occur in the outer retina prior to changes in 
the RPE (Gume et al. 1991; Penfold et al. 1991; Madigan et al. 1994). Increasing 
evidence acknowledges the involvement of the neural retina in the pathogenesis of 
AMD (Madigan et al. 1994; Penfold et al. 1997; Gupta et al. 2003; Wu et ai. 2003). 
As immunocompetent antigen-presenting dendritic cells with a range of cytotoxic 
and immunological responses, retinal microglia and choroidal leukocytes are two 
possible candidate cell populations for angiogenic signals to choroidal 
neovascularisation and modulation of the inflammatory response in exudative AMD. 
' 
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Table 3. 7 Manual Counts of CD45-Iabelled Choroidal 
Leukocytes in frozen sections 
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Aged Normal eyes 
+17% p<0.001 
+79% p<0.001 
-36% p<0.001 
-57% p<0.001 
-43% p<0.001 
+144% p<0.001 
Table 3. 7 Manual counts of immunoperoxidase-labelled CD45-positive choroidal 
leukocytes in AMD subgroups compared with Aged Normals and Young Normals. Overall, 
a significant increase in numbers of CD45-positive ce11s is seen in AMD specimens 
compared to Aged Normals (17%, p<0.001). In particular, the disciform scar (79%, 
p<0.001 ) and pigmentary disturbance (144%, p<O.OOI) subgroups show a significant 
increase in CD45 expression relative to Aged Normal specimens. 
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The basis for studying CD45 expression in AMD includes its exclusivity as a 
leukocyte marker, its effectiveness as a specific immunological marker for microglia 
and choroidal leukocytes, and its primary role in immune regulation in a number of 
pathological processes via signal transduction through antigen receptors. CD45 
expression has been shown to be upregulated on activated microglia in 
neurodegenerative and neuroinflammatory diseases (Masliah et al. 1991; Carpenter 
et al. 1993; Versijpt et al. 2003). The expression of CD45 on retinal microglia and 
choroidal leukocytes in AMD and subgroups of AMD has not previously been 
examined. As such, this study aimed to quantify the expression of CD45 on retinal 
microglia and choroidal leukocytes in AMD retinae compared with age-matched 
normal and young adult retinas, using quantitative immunohistochemical techniques. 
It also aimed to determine if there are differences in CD45 expression in the different 
subgroups of AMD, including incipient and late stage disease. The specificity of 
CD45 to leukocyte lineage cells, including microglia, combined with image analysis 
technology provides a practical and theoretical basis for the measurement of the 
inflammatory cell content of ocular tissue. 
3.4.1 The role of microglia in the pathogenesis of 
AMD 
3.4.1.1 Morphological changes 
This study supports the hypothesis that microglia play a role in the pathogenesis of 
AMD. The findings suggest a generalized hypertrophy of microglia in eyes affected 
by pathological changes of AMD in the outer retina. In AMD retinae, morphological 
changes in microglia included a more globular appearance, increased thickening and 
vacuolation of processes, particularly in the late stage disciform scar lesions, 
consistent with that observed in activated microglia (Vrabec 1975; Gehrmann et al. 
1995; Minghetti and Levi 1998). This is likely to reflect changes from increased or 
de novo expression of immunomolecules including cytotoxic and inflammatory 
mediators. A recent study found that the enlarged, amoeboid morphology of 
activated microglia in AMD and other retinal degenerative diseases reflected 
cytoplasmic inclusions from phagocytosis of photoreceptor components (Gupta et al. 
2003). Consistent with these findings, it has been postulated that activated microglia 
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migrate to the outer nuclear layer and are implicitly associated with photoreceptor 
death and removal of cellular debris (Gupta et al. 2003). The exact nature of the 
inflammatory signals is still unclear, however there is increasing evidence that 
microglia have a central function in the pathogenesis of AMD, whether in a primary 
initiating role or in a secondary reactive response to other insults. 
3.4.1.2 CD45 expression in retinal microglia 
This study found increased CD45 expression in retinal microglia in AMD lesions 
compared to age-matched controls, which in turn was higher than in young controls. 
Increased CD45 expression appears to indicate an upregulation of microglial 
function in the presence of an immune response, possibly reflecting increased signal 
transduction activity and antigen presentation, key features of dendritic cells. These 
observations support previous evidence that microglia become activated from an 
insult to neural tissue and that this response parallels the responses of cells of the 
immune system (Streit et al. 1988; Thomas 1992). This study also found that there 
was a differential expression of CD45 within the different subgroups of pathological 
AMD tissue, a fmding not previously reported. Increased CD45 expression was 
found in the disciform scar and pigmentary disturbance groups compared to age-
matched controls. Some investigators have reported that microglia show a specificity 
and plasticity in their response to different forms of pathological changes in neural 
tissue (Flaris et al. 1993). Whether this is a secondary response to different 
underlying pathologies or whether there is a primary role for microglia in modifying 
or altering pathological responses remains unknown. In disciform scar lesions, 
microglia may contribute more to the promotion of angiogenesis and choroidal 
neovascuJarisation and fibrovascuJar response than in atrophic forms of AMD. It is 
well established that microglia are potential sources of angiogenic cytokines and 
proinflammatory mediators such as VEGF, TNF-alpha and nitric oxide (Gehrmann et 
al. 1995; Minghetti et al. 1999; Nakanishi 2003). Pigmentary disturbance of the RPE 
has been shown clinically to be a significant independent risk factor for the 
development of choroidal neovascularisation (Bressler et al. 1990). As there may be 
different levels of microglial activation in response to pathological stimuli 
(Gehrmann et al. 1995), this immunohistopathological study postulates that 
inflammatory processes may be present across a spectrum of AMD, possibly with 
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moderate levels of microglial activation in the incipient forms of the disease and 
greater levels in late lesions. The graded transformation into phagocytic macrophages 
may parallel processes found in T cell-mediated autoimmune injury of the nervous 
system where microglial activation occurs at an early stage of disease development 
(Gehrmann et al. 1995). 
3.4.2 The role of choroidal leukocytes in the 
pathogenesis of AMD 
Whilst there is a potential role for choroidal leukocytes to promote angiogenesis in 
AMD (Auerbach 1981; Penfold et al. 1984), plugging or queuing of choroidal 
leukocytes has also been associated with degeneration of the choriocapillaris and 
atrophy of capillary segments in other choroidopathies (Lutty et al. 1997). 
Degeneration of the choriocapillaris and reduction of choroidal blood flow have been 
reported to be associated with AMD and deposits in Bruch's membrane (Lutty et a!. 
1999). It is also possible that increased "stickiness" of choroidal leukocytes 
associated with elevated inflammatory processes and increased secretion of adhesion 
molecules may further compromise the choroidal vasculature and promote dropout 
and dysfunction. The highest numbers of CD45-positive choroidal leukocytes were 
found in the pigmentary di sturbance subgroup followed by the disciform scar 
subgroup. This finding may reflect early plugging of choroidal leukocytes in one 
incipient form of AMD, that may lead to compromised choroidal blood flow and a 
stimulus to angiogenesis. 
Decreased choroidal blood flow has been demonstrated to be associated with ageing 
(Grunwald et al. 1998), choroidal neovascularisation (Mori et al. 200 1) in exudative 
AMD and non-exudative AMD (Grunwald et al. 1998). The expression of CD45 in 
subgroups of AMD showed that there were less choroidal leukocytes in frozen 
sections in drusen, geographic atrophy and basal laminar deposit specimens 
compared to age-matched normal controls, a similar differential trend found on 
retinal microglia as well as choroidal leukocytes. This may reflect reduced choroidal 
blood flow or perhaps a thinner choriocapillaris in these AMD subgroups compared 
with the disciform and pigmentary disturbance subgroups. 
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3.4.3 Differential 
microglia and 
subgroups 
expression of CD45 
choroidal leukocytes 
on 
in 
retinal 
AMD 
Clinically and histopathologically, there are significant differences in the nature of 
the incipient, late, exudative and atrophic forms of AMD. The pathogenetic 
mechanisms which cause some retinae to develop choroidal neovascularisation more 
acutely, or evolve into the atrophic form of AMD, and those mechanisms which 
induce maturation or regression of choroidal neovascularisation into inactive scars 
remain to be fully understood (Zarbin 1998). Whilst many hypotheses including 
metabolic stress, hypoxia and RPE ischaemia (Castillo et al. 2002; Feher et al. 2003 ; 
Schlingemann 2004) have been proposed, the role of the immune system in the 
promotion and regression of AMD as well as the varied histopathological expression 
of different subtypes of AMD deserves consideration. 
There is increasing evidence for the involvement of acute and chronic inflammatory 
processes in the pathogenesis of AMD. The slower, insidious progression of the 
atrophic form of AMD may represent a more chronic inflammatory response. 
Quantitative analysis of CD45 expression on microglia in retinal flatmounts also 
demonstrated lower levels of expression in GA specimens than age-matched 
controls. This may reflect a generally slower development of GA, suggestive of a 
more chronic response than the relatively acute nature of choroidal 
neovascularization. The present study demonstrated morphology consistent with 
microglial activation in all subgroups of AMD compared to age matched controls. In 
this study, microglia had a more activated morphology, with a less ramified 
appearance in disciform scar specimens compared to other AMD specimens. This 
agrees with the findings that there is a spectrum of microglial activation and 
transformation into phagocytic macrophages in response to pathological stimuli 
(Gehrmann et al. 1995). The range of responses of microglia may represent a part of 
the underlying pathogenetic differences between the subgroups of AMD. The finding 
of increased leukocyte numbers, correlated with increased CD45 expression on 
choroidal leukocytes by quantitative analysis in late AMD lesions compared to 
incipient AMD lesions (Table 3.6), further supports the notion that there may be 
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underlying differences in the choroidal leukocyte population which dictate the 
evolution to the exudative or atrophic forms of AMD. Further histopathological 
studies are required to answer these questions. 
3.4.4 Validity of Quantitative Fluorescent 
Immunohistochemistry Technique 
The technique of quantitative immunohistochemistry based on immunofluorescence, 
scanning laser confocal microscopy and digital image analysis was found to be 
reproducible and reliable. In the quantitative assessment of CD45 expression on 
choroidal leukocytes, the automated image analysis technique correlated with 
masked manual counts. Whilst the accuracy of the quantification of protein 
expression of this technique may be not as high as with other molecular techniques, 
immunohistochemistry allowed the dual function of in situ morphological analysis, 
in addition to comparison of antigen expression within normal and pathological 
tissue. The maintenance of rigorous standards across experimental runs for both 
normal and AMD specimens allowed repeatable comparative estimation. Although 
some disadvantages of this technique include photobleaching and steric hindrance, 
advantages of using confocal microscopy include increased accuracy and more 
precise sampling compared to light microscopy optical densitometry. In this study it 
was also possible to compare the levels of expression of a particular protein in 
different tissues by sufficient sampling of smaller regions and maintaining strict 
standard protocols across all specimens examined. The specimens used in this study 
were human donor specimens obtained subsequent to informed consent from the 
NSW Lions Eye Bank. As donor tissue with pathological AMD lesions is often 
difficult to obtain, the findings of this study were based on smaller numbers of 
specimens. Larger sample sizes in future studies may be helpful in confirming these 
findings. 
3.4.5 Summary 
The present study showed that CD45 expression is upregulated on retinal microglia 
and choroidal leukocytes in AMD retinae, compared with age-matched normal and 
young adult retinas, using quantitative immunohistochemical techniques that were 
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shown to be valid and reproducible. The observed differences in CD45 expression 
between AMD subgroups was not unexpected, perhaps reflecting the underlying 
immunological processes that contribute to the evolution of these subtypes, including 
incipient and late stage disease. Whilst many questions remain regarding the 
pathogenesis of AMD, it is hoped this study will contribute to the further 
understanding of the disease. 
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CHAPTER4 
Effects of Triamcinolone Acetonide on Microglial 
Morphology and Expression of CD45 and MHC-11 in 
Exudative Age-Related Macular Degeneration. 
Chapter 4: Effects of Triamcinolone on Microglia., CD45 and MHC-II expression in exudative AMD 
t\.1\N'I"ROD\JC'I\ON 
Intravitreal administration of corticosteroids, including triamcinolone acetonide 
(T A), has been shown to be effective in reducing the incidence of experimentally 
induced neovascularisation in animal studies (Chandler et al. 1985; Ishibashi et al. 
1985; Antoszyk et al. 1993; Danis et al. 1996). Corticosteroids are commonly used to 
tt~\ \n\\.amma\~"t'j e~e ~\~eo.~e~ '?!!\~ ~~\1 ~~\~~'t~\\'- ~~\'t\\\\~\ \~\ ~t \\t~\\\\t\\\ (,)\. 
exudative AMD, via intravitreal administration is currently being examined (Gillies 
et al. 2003; Jonas et al. 2003). Recent studies have examined the efficacy and toxicity 
of intravitreal T A concluding that it may provide at least short-term improvement in 
visual acuity and fundus findings in occult and classical exudative AMD (Danis et al. 
2000; Jonas et al. 2003). 
Corticosteroids have been administered for inflammatory eye diseases by topical , 
sub-Tenons (Jennings et al. 1988) and orbital floor injection techniques (Riordan-Eva 
and Lightrnan 1994). More recently however there has been significant interest in 
intravitreal administration of corticosteroids for the treatment of ocular conditions 
including posterior uveitis, cystoid macular oedema and diabetic maculopathy 
(Benhamou et al. 2003; Jonas et al. 2003a-c; Massin et al. 2004). This class of 
hormone is known to exert anti-inflammatory effects upon immune function in 
multiple ways (Cronstein et al. 1992; Tanaka et al. 1997). Recent studies have also 
suggested that glia actively modulate neural tissue function throughout life via the 
action of steroids (Jordan 1999; Melcangi et al. 1999). Other studies have shown that 
glia possess steroid receptors, may be direct targets for steroid hormones and that the 
promoter regions of glial-specific genes such as GF AP and glutamine synthetase 
contain hormone-responsive elements (Jordan 1999). The retina contains both 
microglial and macroglial (Muller cells and astrocytes) populations, and Muller cells 
are the most abundant retinal cell with a critical role in maintaining ion balance and 
recycling excitatory neurotransmitters (Nagelhus et al. 1999). Activation of Muller 
cells has recently been observed to be associated with drusen and photoreceptor 
degeneration in AMD retinae (Johnson et al. 2003). 
As described in Chapters I and 3, microglia play an active role in neural 
inflammatory, immune and degenerative processes, contributing to host defence, 
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repair and the establishment and maintenance of neural damage (Minghetti and Levi 
1998). Microglia synthesize and release proinflammatory and vasoactive substances 
including cytokines, neurotransmitters, nitric oxide, prostanoids and toxins 
(Gehnnann et al. 1995; Nakanishi 2003). Corticosteroids have been shown to directly 
inhibit microglial and macrophage proliferation and activation in other disease 
models (Badie et al. 2000). Other studies have found that steroids inhibit synthesis 
and secretion of proinflammatory cytokines from microglia and vascular endothelial 
cells including complement Clq (Walker 1998), IL-l~ (Yao and Johnson 1997) and 
VEGF (Nauck et al. 1998) via down-modulation of the VEGF gene. Subsequently, 
possible mechanisms of steroids in the treatment of retinal inflammatory disease may 
involve suppression of retinal glial cells via steroid receptors (Melcangi et al. 1999) 
or inhibition of inflammatory agents from choroidal leukocytes. The results in 
Chapter 3 and previous studies (Penfold et al. 1997; Gupta et al. 2003) support the 
fmding that microglia become activated in AMD retinae. 
Expression of MHC-Il glycoproteins is a functional characteristic associated with 
antigen-presenting cells of haematopoietic origin (Steinman I 991). Aberrant MHC-II 
expression by nonhaematopoietic cells has, however, been shown to promote 
inactivation ofT cells and immunological unresponsiveness (Phipps et al. 1989). In 
addition, aberrant or diffuse expression of MHC-11 antigens by retinal vascular 
endothelial cells is not inconsistent with apparent absence of lymphoid cells within 
the retinal parenchyma (Liew et al. 1994). Retinal microglia constitutively express 
MHC-11 (Provis et al. 1995). Expression of MHC-11 on microglia and vascular 
endothelial cells has been found to be upmodulated in AMD retinae, especially in the 
incipient forms of the disease (Penfold et al. 1997). Induction of MHC-11 antigen 
expression on microglia is also a feature of several other CNS pathologies including 
Alzheimer's disease (Tooyama et al. 1990) and HIV/ AIDS (Kamp et al. 2001). 
In this clinicopathological case study, an 81 year old female patient with bilateral, 
recent onset subfoveal choroidal neovascularisation was enrolled in a Phase II open-
label triamcinolone treatment pilot study (Penfold et al. 1995). One eye was treated 
with an injection of intravitreal T A, whilst the fellow eye was not. Sadly she died 6 
weeks later from an unrelated cause but donated her eyes for research. This allowed a 
unique opportunity to examine histopathologically the in vivo effects of intravitreal 
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corticosteroids on retinae with exudative AMD. The present study employs the 
quantitative immunofluorescence digital image analysis techniques developed in 
Chapters 2 and 3 to investigate and quantify the expression of CD45 and MHC-II 
antigens in corticosteroid (TA)-treated and untreated retinae, associated with 
choroidal neovascularisation. 
Although the cellular origins of the signals that initially provoke choroidal 
neovascularisation have not been defmed, it is proposed that microglia as resident 
immune cells of the retina, comprise a suitable target population for the anti-
inflammatory effects of corticosteroids. Inhibition of microglia and choroidal 
leukocytes and their neovascular signals may contribute to a possible therapeutic 
mechanism of action of TA in the treatment of choroidal neovascularisation. 
4.2METHODS 
4.2.1 Clinical Details 
An 81 year old female presented with a few weeks history of distorted and 
blurred vision in both eyes. Her best corrected visual acuity on presentation was 6/36 
in her left eye and 6/18 in her right eye. Intraocular pressures were 14 mmHg in her 
left eye and 17 mmHg in her right eye, and she presented with mild bilateral lens 
nuclear sclerotic cataract. Her background medical history included hypertension and 
congestive cardiac failure and she was an ex-smoker. Fundoscopy revealed bilateral 
macular serous elevations and some macular pigmentary disturbance in her left eye 
(Figure 4.1). Fluorescein angiography demonstrated similar bilateral, medium-sized 
mixed subfoveal choroidal new vessels, predominantly occult in nature (Figure 4.3). 
The patient received an intravitreal dose of 4mg T A by pars plana injection into her 
left eye only, according to a pilot study protocol (Penfold et al. 1995). The right eye 
was not treated. A few days after the treatment, she noted an improvement in the 
vision in her treated eye, with acuity improving to 6/24 after 2 weeks. Fundoscopy 
and fluorescein angiography 2 weeks after treatment revealed a slight reduction in 
serous elevation and fluorescein leakage (Figure 4.2). Sadly, six weeks after the 
treatment the patient died as a result of unrelated cardiovascular failure, however her 
family donated her eyes for research purposes and histopathological survey. 
Figure 4.1 Pre-treatment fundus photos showing bilateral subretinal 
neovascular membranes with serous macular elevations (arrowheads) 
and surrounding oedema from choroidal neovascularisation (courtesy of 
Dr A. Hunyor). 
Figure 4.2 Left fundus photos A. Before intravitreal triamcinolone (T A) 
injection and B. 2 weeks after treatment, showing slightly reduced macular 
serous elevation (white arrow) and TA crystals within the vitreous (black 
arrows) (courtesy ofDr A. Hunyor). 
Figure 4.3 Early and late phase fluoroscein angiogram$ of the 
choroidal neovascular membrane (left eye) before intravitreal 
triamcinolone treatment (A,B), 2 weeks following treatment (C,D) and 6 
weeks following treatment (E,F), with similar post-injection times. The 
appearance of the choroidal neovascularisation shows minimal change, 
with only mild changes in late phase hyperfluorescence at 6 weeks post 
treatment (courtesy of Dr A. Hunyor). 
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4.2.2 Tissue Preparation 
Eyes, including TA-treated, untreated spec!mens and an age-matched normal control 
specimen, were obtained for research purposes subsequent to informed consent 
through the NSW Lions Eye Bank lffid with approval of the Human Ethics 
Committee (University of Sydney). Following removal of the anterior segment and 
vitreous, the remaining retina, choroid and sclera were fixed in 2% 
paraformaldehyde/ O.lM PBS (pH 7.4) and stored at 4°C. Post mortem delay from 
time of death to fixation was. 24.5 hrs; delay from time of death to time of 
enucleation was 8.25 hrs. The control specimen was from an 80 year old female, with 
post mortem delay time to fixation of·ts:s 'hrs and delay time to enucleation of 10 
hrs. Using 7mm and 4mm trephines, discs" of tissue comprising all ocular layers from 
neural retina to sclera were cut from correSponding macular and paramacular 
locations. The neural retina was dissected .away' from the RPE and choroid and was 
prepared for immunohistochemistry as flagnounts (see Chapter 3). Using 7mm and 
4mm trephines, cliscs of tissue comprising" all 'ocular layers from neural retina to 
sclera were cut from corresponding macuiar and paramacular locations. adjacent 
4mm full thickness discs of all ocular layers were frozen in Tissue Tek1M medium 
OCT (Sakura, Japan) using liquid nitrogen..::cooled isopentane and cut as 20 J.1m thick 
frozen sections. The RPE and choroid frob macular trephines were postfixed in 
2.5% glutaraldehyde and 2% osmium tetroxide, bloc stained in uranyl acetate, 
dehydrated through graded alcohols and acetone and embedded in Epon-araldite 
resin (ProSciTech, Australia) and cured at 60°C. Semithin sections were cut using a 
Reichert U1tramicrotome, stained with toluidine blue and examined by light 
microscopy. 
4.2.3 Immunohistochemistry 
4.2.3.1 Quantitative Immunoflup.rescence (see Chapter 3) 
Briefly, flatmount specimens were single-labelled with a 3-step indirect 
immunofluorescent technique for subseguent quantitative image analysis as 
described in Chapter 3. Following serum blocking (10% normal sheep serum/ 0.4% 
saponin/ TBS), specimens were incubated for 5 days in either of the following 
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primary antibodies: mouse anti-human HLA- DP,DQ, DR (Major Histocompatibility 
Class II, 1:50 dilution, DAKO) or mouse anti-human CD45 (Leukocyte Common 
Antigen, anti-HLE-1, 1:50 dilution, Becton Dickinson). Retinae were then incubated 
in secondary antibody (biotinylated sheep anti-mouse IgG, 1:50, Amersham 
Phannacia Biotech) for 48 hrs followed by fluorochrome (streptavidin-conjugated 
Cy3, 1:100 Zymed Laboratories) for 3 hours before mounting in glycerol on gelatin-
coated slides and coverslipped. 
4.2.3.2 Frozen Sections 
Frozen sections were double immunolabelled using CD45 and GF AP to visualize the 
morphological relationship of CD45-1abelled microglia and GFAP-labelled 
macroglia (astrocytes and Muller cells) in the foUowing manner. Slides were rinsed 
in 0.1M PBS (pH 7.4) for 5 mins then preincubated in 10% normal sheep/ 10% 
normal goat serum/ PB$ for 15 mins to red!lce background labelling. Specimens 
were then incubated in a mixture of mous~ anti-human CD45 (1 :50 dilution/ 2% 
normal sheep serum/ PBS) and rabbit anti-cow GF AP (1: 1000 dilution I 2% normal 
goat serum/ PBS) oyernight on a shaker .table at 4°C. Following rinsing in PBS, 
./ 
sections were incubated in secondary antibody in a mixture of biotinylated sheep 
anti-mouse IgG (Amersham Pharmacia Biotech, I :50 dilution/ 2% normal sheep 
serum) and Cy5-conjugated anti-rabbit IgG (Laboratories, 1:50 dilution/ 2% normal 
goat serum). Streptavidin-conjugated Cy3' (1: 100 dilution/ PBS, Zymed 
Laboratories) was used to visualise the CD45 labelling. Specimens were mounted in 
a glycerol-based anti-fade agent 1,4-diazabicyclo[2.2.2]octane (DABCO) and 
covers lipped for viewing. 
4.2.3.3 Indirect Immunoperoxidase Labelling 
Flatmounts and frozen sections of treated, untreated and control specimens were also 
labelled with an indirect immunoperoxidase labelling technique in order to correlate 
the quantitative image analysis technique with masked manual counting. CD45 and 
MHC-II labelling in flatmounts and CD45 labelling in frozen sections was visualized 
using ExtrAvidin-Peroxidase (1:200 dilution, Sigma, Australia) and Sigmafast 3,3'-
Diaminobenzidine tablet sets, using the same primary and secondary antibody 
protocol as previously described. Specimens were then dehydrated through graded 
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alcohols, cleared in xylene then mounted and coverslipped in DePeX (BDH Pty Ltd, 
Australia) for examination under standard light microscopy. CD45 and MHC-II 
immunolabelled cells were manually counted'in a masked fashion using an Olympus 
microscope and x40 objective with 0.2mm graticule. 
4.2.4 Confocal Microscopy 
Retinal flatmounts were examined with a Leica TCS-NT scanning laser confocal 
microscope system (Leica Microsystems Heidelberg GmbH, Germany). 
Fluorochrome-labelled specimens were stimulated by argon-krypton laser at 568nm 
and optical sections were collected by photomultipliers using a PL APO 16x oil-
immersion objective and appropriate band-pass filters. Standardized settings 
including photomultiplier gain, offset, aperture and laser power were maintained 
rigorously to allow comparison of cell .~uorescence intensity between different 
specimens. A standardized 3-dimerisional optical grid was placed over each 
specimen and five random fields were analysed per flatmount (see also Chapter 2). 
4.2.5 Digit~l Image Analysis 
Antibody expression was objectively quantified using ·digital image analysis of 
confocal immunofluorescence-labelled images (see Figure 3.1). Optical sections 
were imported into the NIH Image program< (National Institute of Health, USA). 
Segmentation of immunoreactivity was achieved using a standardised custom 
histogram-based thresholding teclmique ahd then subjected to particle analysis. 
Parameters recorded included percentage area of field labelled, and total fluorescence 
intensity per field. 
4.2.6 Statistical Analysis 
·. 
Measurements from treated, untreated and control specimens were compared 
statistically by two-tailed unpaired Student's t tests, using the lnstat statistical 
program (GraphPad Software Systems). 
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4.3 RESULTS 
4.3.1 Light Microscopy Histopathology 
The treated and untreated retinal and choroidal sections showed similar early mixed, 
predominantly occult, fibrovascular lesions. Both lesions contained inflammatory 
cells including leukocytes and early fibrova&cular organisation (Figure 4.4). Both 
specimens showed sub-RPE exudation, which was less pronounced in the treated 
eye. 
4.3.2 Immunohistochemi~try 
4.3.2.1 CD45 Immunoreactivity 
CD45 immunoreactivity was localized on microglia in three main layers within the 
vascularised inner retina in a regular distribution in flatmounts of treated, untreated 
and control specimens. Labelling was evident on the three main microglia types: 
parenchymal (ramified type) microglia, vessel-associated microglia located in the 
parenchyma (paravascular macrophages) and vessel-associated microglia in the 
perivascular spa~e (perivascular macrophages) (see figure 3.2). The total area 
reactive to ~D45 in theTA-treated specimen was 27% less than that in the untreated 
specimen (6.9 +/- 1.6% vs 9.5 +/- 1.3%, p<0.05) and control specimen (8.6 +/- 1.5%) 
(Table 4.1). Total fluorescence intensity in theTA-treated specimen was 32% less 
than in the untreated specimen (27.9 +/- 7:0 ·flnorescence units (fu) vs 41.0 +/- 6.2 fu, 
p<0.05) and control specimen (34.2 +/- 5.5 ~) (Table 4.2). 
Masked manual counts of microglia in retin~l flat~ount specimens showed 33% less 
microglia in theTA-treated (261.6 +/- 21_.4 cells/mm2) vs the untreated group (387.6 
+!- 31.2 cells/mm2, p<0.05) and control group (335.8 +/- 25.7 cells/mm2) (Table 4.3). 
In the untreated AMD specimen, vessel-associated and parenchymal microglia were 
hypertrophic with thickening of cellular processes, swollen cell bodies and 
occasionally showed terminal varicosities (Figure 4.5a,b). In the treated retina, the 
microglia were less hypertrophied, had thinner processes and labelled less intensely 
with CD45 and generally showed less signs of overt activation (Figure 4.5c,d). 
Vascular endothelial cells were not labelled with CD45, however were 
immunoreactive for MHC-II. Sections doubled-labelled with CD45 and GFAP 
Figure 4.4 Semi thin resin sections of outer retina of untreated (A) and triamcinolone-
treated (B) specimens, showing bilateral fibrovascular complexes established between 
Bruch's Membrane (arrowheads) and RPE basement membrane (arrows), involution and 
sclerosis of the choriocapillaris and choroidal vessels and sub-RPE oedema (asterisks) 
more prominent in the untreated lesion (Bar= 30J.UI1) (courtesy of Dr P. Penfold). 
Figure 4.5 Immunoperoxidase-labelled CD45-positive microglia in untreated 
AMD retina (A,B) and triamcinolone-treated AMD retina (C,D). Microglia in the 
treated specimen show less hypertrophy and a less activated morphology. 
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Table 4.1 Quantitative analysis of total retinal flatmount area labelled 
with CD45 in T A treated, untreated and control specimens, showing a 27% 
decrease in CD45 expression in treated compared to untreated specimens 
(p<0.05). 
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Table 4.2 Quantitative analysis of total fluorescence intensity of CD45-
positive microglia in retinal flatmounts in T A treated, untreated and control 
specimens, showing a 32% decrease in CD45 expression in treated compared 
to untreated specimens (p<0.05). 
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Table 4.3 Manual counts of CD45-positive microglia in retinal flatmounts 
of T A-treated, untreated and control specimens showing a 33% decrease in 
the number of CD45-positive cells in treated compared with untreated 
specimens (p<0.05). 
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identified the morphological relationships between microglia and astrocytes, 
predominantly in the nerve fibre layer (Figure 4.6). 
Indirect peroxidase labelling of CD45 in retinal and choroidal frozen sections 
demonstrated three main layers of microglia in the neural retina as described in 
Chapter 3, and also showed CD45-labelled leukocytes within the choroidal 
vasculature (Figure 4.7). Masked m~ual colll}.ts of numbers of retinal microglia and 
choroidal leukocytes in frozen sections showed 33% lessl microglia in sections in the 
treated (4.24 +/- 0.13 cells/ mm2) vs the untreated (6.26 +/- 0.22 cells/ mm2) (p<0.05) 
and control (6.12 +/- 0.1 cells/ mm2) specimens (Table 4.4). IntereStingly a 45% 
increase in choroidal leukocytes was found jn theTA-treated specimen (7.28 +/- 0.30 
cells/ mm2) compared with the untreated (4.04 H- 0.26 cells/ mm2) and control (5.39 
+/- 0.18 cells/ mm2) specimens'(Table 4.5). 
4.3.2.2 MHC-11 Immunoreactivity 
MHC-II immunoreactivity was present on retinal microglia and vascular endothelial 
cells. MHC-II antigens were localized Qn three main microglial types (parenchymal, 
/ ... 
vessel-associate<! perivascular and paravascular types) 'in three distinct layers within 
/ ' 
the vascularised inner retina i~ a 'regular distribution. Intense MHC-II 
immunoreactivity appeared to be preserved on vessel-associated micrqglia in the T A 
treated specimen as well as the untreated specimen (Figure 4.8). Quantitative 
analysis demonstrated that retinal flatmount field area expressing MHC-II antigen 
was reduced by 33% in the TA-treated (18.6 +/- 3.8%) compared with untreated 
(27.7 +/- 3.1%, p<0.05) and _control (25.1 +/- 2.8%) specimens (Table 4.6). There 
was also a small, but insignificant reduction of total intensity of MHC-II expression 
between untreated (44.0 +/- 8.0 fu), TA-treated (38.4 +/- 18.2 fu, p>0.05) and control 
(40.2 +/- 3.5 fu) specimens (Table 4.7). Manual counts ofMHC-II-labelled microglia 
also showed a significant difference in microglial numbers in retinal flatmounts 
between untreated (321.9 +/-45.7 cells/ mm2), TA-treated (116.5 +/-38.4 cells/ mm2) 
and control (322 +/- 58.9 cells/ mm2) specimens (p<O.OOl) (64% decrease, Table 
4.8). In the untreated AMD specimens, as with CD45-labelled cells, parenchymal 
microglia were more hypertrophic with thickening of cellular processes, swollen cell 
bodies and occasionally showed terminal varicosities. In the TA-treated retina 
Figure 4.6a Untreated AMD retina (A) and triamcinolone-treated AMD 
retina (B) double-labelled with CD45 (red) and GF AP (glial fibrillary acidic 
protein) (blue) demonstrating the relationship of macroglia (astrocytes) and 
microglia (MG) in the NFL. 
Figure 4.6b Higher magnification of untreated AMD retina double-
labelled with CD45 (red) and GFAP (glial fibrillary acidic protein) (blue) 
demonstrating increased microglial hypertrophy and increased intensity of 
astrocyte labelling. 
Figure 4. 7 Immunoperoxidase-labelled CD45-positive microglia (arrows) in 
triamcinolone- treated retina demonstrating a laminar distribution. CD45-positive 
leukocytes are seen in the choroid (arrowheads). 
'A. ·l .. 
Figure 4.8 Immunoperox.idase-labelled MHC-11-positive microglia and 
vascular endothelial cells in untreated AMD retina (A,B) and triamcinolone-
treated AMD retina (C,D). Microglia in the treated specimen show less 
hypertrophy and a less activated morphology, with similar levels of expression of 
MHC-D in treated specimens. 
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Table 4.4 Manual counts of CD45-positive retinal microglia in frozen 
sections of TA-treated, untreated and control specimens showing a 33% 
decrease in the number of CD45-positive cells in treated compared with 
untreated specimens (p<0.05). 
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Table 4.5 Manual counts ofCD45-positive choroidal leukocytes in frozen 
sections ofT A-treated, untreated and control specimens. Interestingly a 45% 
increase in the number of CD45-positive cells is seen in treated compared 
with untreated specimens (p<0.05). 
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Table 4.6 Quantitative analysis of total retinal flatmount area labelled 
with MHC-II in TA treated, untreated and control specimens, showing a 33% 
decrease in CD45 expression in treated compared to untreated specimens 
(p<0.05). 
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Table 4. 7 Quantitative analysis of total fluorescence intensity of MHC-11 
positive cells in retinal flatmounts in T A treated, untreated and control 
specimens, showing a small but not significant reduction in MHC-TI 
expression in treated compared to untreated specimens (p>0.05). 
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Table 4.8 Manual counts of MHC-11 positive microglia in retinal 
flatmounts of TA-treated, untreated and control specimens showing a 
significant decrease in MHC-11 expression in treated compared with untreated 
specimens (p<O.OOl). 
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parenchymal microglia were reduced in numbers and generally had a more 
condensed morphology (Figure 4.8). 
4.4 DISCUSSION 
The rationale for using anti-inflammatory corticosteroids in the treatment of 
exudative AMD has been deriv~ from independent observations regarding the 
involvement of both humoral and cell-mediated immunity in the pathogenesis of 
AMD. The presence of anti-retinal antibodies in sera from patients with drusen, RPE 
pigmentary disturbance and early ,exudative AMD has been previously reported 
(Penfold et al. 1990; Gume et al. 1991). In addition, both the atrophic and 
neovascular endstages of AMD involve cell-med~ated inflammation, and evidence of 
leukocyte sticking and extravasation has been observed ultrastructurally (Penfold et 
al. 1987). Recently, it has been shown that immune and inflammatory responses 
appear to be important in the pathogenesis o( drusen immune complexes (Johnson et 
al. 2000; Mullins et al. 2000; Hageman et al. 2001; Anderson et al. 2002). Also, 
chronic inflammatory cells including macrophages, lymphocytes and plasma cells 
have been reported in surgically excised neovascular membranes (Lopez et al. 1991). 
,. 
Corticosteroids have diverse immunomodulatory and anti-inflammatory effects in 
neural tissue, mediated by glucocorticoid and mineralocorticoid receptors (Reul et al. 
1987). Possible anti-inflammatory mechanisms of corticosteroids include attenuation 
of the expression of adhesion molecules such as intercellular adhesion molecule -1 
(ICAM-1) and endothelial-leukocyte adliesion' molecule-1 (ELAM-1) (Cronstein et 
al. 1992). Also, TA down-regulates expression of ICAM-1 in vivo m an 
inflammatory BRB model of macular degeneration (Penfold et al. 2000) .Other 
studies have suggested that steroid treatment can decrease GF AP expression in brain 
astrocytes (Nichols 1999); GFAP has 'also been found to be aberrantly expressed in 
macroglia in AMD retinae (Madigan et al. 1994; Wu et al. 2003). Another study 
demonstrated that steroids regulate function and morphology of microglia via 
differential effects on glucocorticoid and mineralocorticoid receptors (Tanaka et al. 
1997). 
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Corticosteroids are commonly used to treat inflammatory ocular diseases, including 
posterior uveitis and sympathetic ophthalmia where cell-mediated and humoral 
immunity are involved (Jennings et al. 1988; Hakin et at. 1992; Riordan~Eva and 
Lightman 1994). In addition, intravitreal administration of corticosteroids, including 
TA has been shown to be effective in reducing the incidence of experimentally 
induced neovascularisation in animal models including monkeys (Ishibashi et al. 
1985), rabbits (Chandler et al. 1985; Antostyk et al. 1993), pigs (Danis et al. 1996) 
and rats (Ciulla et al. 2003). The possible mode of action of corticosteroids in the 
treatment of exudative AMD, including effects on different retinal cell populations 
has not been fully defined. As the intrinsic immunoeffector cell of the neural retina, 
with the ability to influence a range of pathologies, microglial cells comprise a 
suitable target population for the immunomodulatory effects of corticosteroids. In 
addition, the angiogenic and proinflammatory capacity of choroidal leukocytes may 
I 
present another possible mechanism by which corticosteroids may act in suppression 
of inflammation. The present clinicopathological study illustrates the differential 
effects of TA on retinal microglia and choroidal leukocytes in a patient with 
exudative AMD. 
4.4.1 MHC-I~ Immunoreactivity 
An earlier study reported an increase in MHC~II immunoreactivity on retinal 
vascular elements with normal aging and a further increase on vascular elements, 
with morphological changes in microglia associated with incipient AMD (Penfold et 
al. 1997). Furthermore, the density of MHC-II immunoreactive microglia was 
increased by approximately -10% in AMD retinae (Penfold et al. 1997). Consistent 
with previous studies, the present case report indicates that retinal microglia 
associated with a mixed occult/classical neovascular frond are apparently 
hypertrophic and express increased levels of MHC-11 compared with age-matched 
controls. In a similar lesion in the fellow eye, intravitreal TA administration resulted 
in significant decreases in microglial numbers and a condensed morphological 
appearance; expression of MHC-II antigens by vascular elements appeared 
unchanged. As previously mentioned, expression of MHC-II glycoproteins is a 
functional characteristic associated with antigen-presenting cells of haematopoietic 
origin (Steinman 1991); expression by nonhaematopoietic cells shown to promote 
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inactivation of T cells and immunological unresponsiveness (Phipps et al. 1989). 
Therefore, MHC-11 expression on vascular endothelial cells in AMD-affected retinae 
may represent a means to restrict retinal inflammation (Penfold et al. 1997). Both 
vascular and microglial elements contribute to the area ofMHC-II immunoreactivity 
measured by image analysis; the do~inant contribution to the area of expression 
would appear to be due to microglial expression of MHC-II. TA did not apparently 
affect the vascular expression of M~C-II antigens; the predominant influence 
appeared to result in a condensed motphological appearance and reduced numbers of 
microglia. 
4.4.2 CD45 Immunoreactivity 
In this study, a reduction of immurloreactivity for CD45 on retinal microglia in the 
TA-treated retina by percentage area of field and by total intensity interpretation was 
shown to correlate with the reduction in the total number of microglia by masked 
manual counts. Microglia, also appeared morphologically less active in the treated 
specimen. ·These results may reflect studies which have shown that corticosteroids 
inhibit microglial proliferation via antagonism of GM-CSF and IL-3 cytokines and 
also can cause shrinkage "'f cultured microglia in vitro (Ganter et al. 1992; Tanaka et 
al. 1997). Corticosteroids also have an antiinflammatory action via the arachidonic 
acid pathway. Pfau et al (2000) found that CD45 was involved in regulation of 
inflammation via modulation of arachidonic acid metabolism and cytokine release, a 
potential target mechanism for the action . of corticosteroids via CD45. Triamcinolone 
acetonide has also been shown to be cytotoxic to human glial cells via activation of 
the caspase-3 pathway (Yeung et al. 2003). As CD45 has been demonstrated to be 
upregulated on microglia in various neural pathologies (Masliah et al. 1991 ), 
including AMD (see Chapter 3), the results of the present study suggest that CD45 
immunoreactivity in retinae with choroidal neovascularisation may be downregulated 
by the action of corticosteroids. The finding of increased CD45-labelled choroidal 
leukocytes in the TA-treated specimen compared to the untreated specimen may 
reflect increased recruitment or margination of intravascular choroidal leukocytes. It 
is recognized that systemic corticosteroids may increase the intravascular content of 
leukocytes (Ganong 1997). 
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4.4.3 Clinical Relevance 
Fundus photographs of the left eye following TA-treatment showed some resolution 
of submacular oedema associated with the choroidal neovascularisation, suggesting 
that intravitreal corticosteroids may promote fluid resorption and resolution of 
inflammatory exudation from beneath the neural retina. Muller cells comprise a large 
population of transretinal glia which have important homeostatic functions including 
the maintenance of retinal water flow via electrolyte transport (Nagelhus et al. 1999). 
Reduction of cytokine-rich subretinal .fltiid may help to improve photoreceptor 
function and may partially explain rapid improvements in visual acuity soon after 
administration of triamcinolone. 
Treatments for subfoveal choroidal neovasc.ularisation, including standard and 
photodynamic photocoagulation have been confined to classic lesions with well-
defined borders (Macular Photocoagulation Study Group 1993; Stevens et al. 1997). 
Also, approximately 85% of newly diagnosed choroidal new vessels are of the occult 
and not classic form (Freund et al. 1993). Recent studies have demonstrated that anti-
inflammatory corticosteroids may be effective in promoting resolution of macular 
oedema and inflammatory exudation in occult choroidal neovascularisation (Danis et 
al. 2000; Jonas et al. 2003). In this case study, TA appeared to be useful in the 
treatment of a mixed lesion that had both classic and occult features. Triamcinolone 
acetonide may therefore be a useful therapy in occult lesions where other treatment 
options are limited, or possibly as an adjunct to other treatment modalities such as 
photodynamic therapy. 
Whilst the exact mechanisms of anti-inflammatory steroids in treatment of exudative 
macular degeneration remain to be fully elucidated, modulation of immune function 
and suppression of inflammatory stimuli remain possible modalities. As evidence 
accumulates showing the importance of the immune response and inflammation in 
the pathogenesis of other forms of AMD, it remains to be determined if intravitreal 
corticosteroids may be beneficial in treatment of non-exudative AMD. The effect of 
intravitreal corticosteroids on retinal cell populations and pathogenetic cellular 
mechanisms deserves investigation in further studies. 
·. 
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Chapter 5: Conclusion 
The findings of this thesis support the hypothesis that retinal microglia, choroidal 
leukocytes and the immunofunctional protein CD45 are involved in the pathogenesis 
of AMD. These observations are consistent with numerous studies that show an 
important role for immunological and inflammatory processes in the pathogenesis of 
AMD disease (reviewed Chapter 1). 
The quantitative method developed in this thesis using immunofluorescence, 
scanning laser confocal microscopy and digital image analysis was comparable with 
manual counting techniques and was found to be reproducible and reliable (Chapter 
3 and Appendix II). Furthermore, the application of this quantitative image analysis 
technique in combination with the exclusivity of Leukocyte Common Antigen 
(CD45) antibody for leukocyte lineage cells (including retinal microglia and 
choroidal leukocytes) provides a practical and theoretical basis for the measurement 
of the inflammatory cell content of ocular tissues, as shown in Chapters 3 and 4. The 
use of quantitative immunofluorescence techniques to study the expression of CD45 
immunoreactivity (and other immune markers) in AMD provides an opportunity to 
better evaluate the subtle changes related to the role(s) of leukocytes and 
inflammation in--the pathogenesis of this disease. The benefits of increased accuracy 
and improved standardisation over previous methods of quantitative 
immunohistochemistry and the in situ morphological analysis of constituent cells 
within complex tissues, complements modern molecular techniques in the 
investigation of disease pathogenesis. 
Microglial cells have been shown to respond in a characteristic fashion in AMD, 
displaying morphological evidence of activation and increased expression of immune 
markers - in particular CD45 (Chapters 3 and 4) and MHC-II (Chapter 4). The 
increased expression of CD45 is significant given its exclusive expression on 
leukocytes and recent studies demonstrating its importance in immune regulation and 
as a critical component in signal transduction in T and B lymphocytes. These 
observations are consistent with increasing evidence that the neural retina is involved 
in promoting the pathological changes seen in AMD. Previous histopathological 
studies in AMD have mostly emphasised the pathological changes occurring in the 
outer retina and RPE - the outer blood retinal-barrier. The findings of this thesis 
indicate that AMD can also be associated with changes in the inner retina (Chapters 
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3 and 4), and raises interesting questions regarding the mechanisms involved in the 
initiation of inflammation in the retina, including the role of the inner blood-retinal 
barrier. 
As described previously, choroidal leukocytes were also observed to be involved in 
the various forms AMD (Chapters 3 and 4). Choroidal leukocytes may contribute to 
the pathogenesis of AMD, possibly acting as sources of angiogenic signals to 
neovascularisation or related to the leukocyte plugging of the choriocapillaris 
observed in these studies (Chapter 3) and previously (reviewed Chapter 1). It remains 
to be determined whether retinal microglia. and choroidal leukocytes play a primary 
role in the pathogenesis of the AMD or are important in secondary disease processes. 
There is increasing evidence from clinicai studies that supports the use of anti-
inflammatory corticosteroids in the treatment of AMD. Corticosteroids have diverse 
immunomodulatory and anti-inflanunatory effects in neural tissue, mediated by 
glucocorticoid and mineralocorticoid receptors. Results from the clinicopathological 
case study (Chapter 4) suggest that retinal microglia and choroidal leukocytes, and 
the CD45 protein, are suitable targets for the anti-inflanunatory and anti-angiogenic 
properties of corticosteroids. The growing number of clinical applications for 
corticosteroid treatment in inflammatory and exudative eye diseases provides further 
confinnation of the rationale for the therapeutic application of these agents in the 
treatment of exudative AMD. A differential role for retinal microglia in the 
pathogenesis of the various subtypes of AMD is also apparent in these studies, 
including the incipient and late stage (atrophic) forms of the disease (Chapter 3). One 
suggestion may be that corticosteroids be used to potentially retard/slow down the 
progression of early changes seen in incipient AMD. Further clinical trials are 
needed to assess this possibility. 
Clearly the pathogenesis of AMD involves both immunological and inflammatory 
processes, however many questions remain with regard to the aetiology of AMD, and 
most patients remain untreatable. Further studies are needed to define more clearly 
the role of growth factors in the development of incipient and late forms of AMD; to 
investigate the immunoregulation of retinal microglia and choroidal leukocytes 
(including the potential for corticosteroids to increase microglial production of anti-
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inflammatory cytokines such as IL-10) and to assess whether neuronal-microglial 
interactions may contribute to the pathogenesis of AMD. Continued clinical studies 
of potential therapies that target the underlying cellular mechanisms of this common 
and disabling disease are also critical, perhaps including specific targeting of CD45 
glycoprotein, increasingly recognised as an important immune regulator in various 
pathologies. 
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Appendix! 
APPENDIX I 
Data for age and delay time to fixation for Young Normal, Aged Normal and 
AMD specimens. 
Specimen ·N1,1mber , Age Delay Time to Fixation 
. 
·(years) (hours) 
Young Normal YNl 28 12 
YN2 15 15.5 
•. 
. YN3 "- 21 19.5 
, YN4 19 23 
YN5 25 18 
YN6 15 22.5 
YN7 . 31 23.75 
YN8 5 20.5 
YN9 , , 32 22 
YNIO 1-4 18 
YN11 29 22 
YN12 40 19.5 
Aged Normal ANI 81 11 
AN2 83 9 
AN3 86 13.6 
AN4 73 12 
AN5 75 10 
AN6 74 11.5 
AN7 77 11 
AN8 84 13.5 ' 
AN9 80 15.5 
AN10 86 8 
AN11 88 12 
-
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Specimen Number Age Delay Time to Fixation 
(years) (hours) 
Drusen DRl 88 6.5 
DR2' 83 10 
DR3 ' 82 13.25 
DR4 
, 
79 8 
'DRS 84 12 
DR6 ' . '83 11 
DR7 87 8 
DR8 88 8 
Basal Laminar Deposit BLl . 77 5 
BL2 . 77 7 
BL3 78 8 
Pigmentary Disturbance PDl· 82 8 
I 
PD2 69 12 
PD3 71 16 
I 
--
-- -- -- ---·--
Disciform Scar DSl 71 15.5 
DS2 87 15 
DS3 . 80 10 
DS4 .81 22 
DSS 78 9 
Geographic Atrophy GAl 94 17 
GA2 85 9 
GA3 86 7 
- --
Appendix/] 
APPENDIX II 
Experiments were conducted to test the relationship between the dilution of CD45 
antibody, the concentration of CD45 antigen expressed on U937 cells and the total 
fluorescence intensity measured by quantitative image analysis using confocal 
microscopy (see Methods, Chapter 3). These experiments aimed to verify that 
increased levels of immunofluorescence observed on normal and pathological tissue 
specimens reflected increased levels ofCD45 antigen. 
Background: 
The U937 human cell line was derived from a patient with histocytic lymphoma, 
displays a monoc~ic morphology and expresses CD45 antigen on its cell surface. 
Methods: 
U937 cells (CRL-1593, American Type Culture Collection, USA) were maintained 
in RPMI med_imh (ThermoElectron Pty Ltd) supplemented with 10% heat-inactivated 
FBS, 50 units/mL ~enicillin, 50 J.tg/mL streptomycin and 2mM glutamine 
(ThermoElectron Pty Ltd) at 37°C and in 5% C02• Following several passages, cells 
were pelleted and fixed in 2% paraformaldehyde/ O.lM PBS, frozen in Tissue Tek™ 
medium OCT (Sakura, Japan) using liquid nitrogen-cooled isopentane and cut as 20 
Jlm thick frozen sections, and mounted on glass slides. 
Immunocytochemistry was performed using anti-human CD45 (Leukocyte Common 
Antigen, anti-HLE-1, Becton Dickinson, Australia) primary antibody over a range of 
dilutions: 1:25, 1:50, 1:100 (dilution 0.01 ), 1:200, 1 :500, 1:1000, followed by 
incubation in secondary antibody (biotinylated sheep anti-mouse IgG, · 1:50, 
Amersham Pharmacia Biotech Australia). Cells were then incubated in fluorochrome 
(streptavidin-conjugated Cy2, 1:100 Zymed ,Laboratories, San Francisco, USA) then 
coverslipped. Specimens were examined by confocal microscopy (Figure Appendix 
Ill) and optical sections were subjected to image analysis to obtain measurements of 
total fluorescence intensity on cell groups and individual cells using the NIH particle 
81 
Figure Appendix 11.1 CD45-labelled U937 cells with low and 
high magnification examined by scanning laser confocal microscopy. 
Appendix II 
analysis function. Average and total fluorescence intensity of each cell was analysed 
and correlated against total intensity of the cell groups. 
Results: 
Dilution experiments demonstrated an incremental relationship 
immunofluorescence increased as the concentration of primary antibody increased. 
In Figure Appendix 11.2, at dilutions less than 1:100 (0.01) immunofluorescence had 
not reached saturation (note the steep slope of the curve). A dilution of 1:50 was 
selected for all experiments,. where immunofluorescence was relatively saturated 
(note the flat slope of the curve, Figure Appendix II.2). Individual particle analysis of 
fluorescence intensity demonstrated· a linear relationship against total fluorescence 
intensity of the entire specimens (Figure Appendix II.3), and a constant relationship 
between concentration of antigen and intensity of fluorescence measured. 
Conclusion: 
These studies verified the positive relationship of antigen expression detected with 
immunohistochemistry, and fluorescence intensity measured by quantitative image 
analysis. 
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Figure Appendix 11.2 Dilutional experiments demonstrating an incremental 
relationship between total fluorescence intensity and increasing concentrations of 
CD45 antibody. 
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